header logo image


Page 5«..4567..10..»

Archive for the ‘Longevity Genetics’ Category

Spaceflight does some weird things to astronauts bodies – MIT Technology Review

Monday, November 30th, 2020

The Twins Study gave us a first sketch of the human bodys molecular responses to spaceflight, but these outlines needed to be filled in, says Christopher Mason, an associate professor of physiology and biophysics at Weill Cornell Medicine. The changes we saw needed more context and replication. We needed additional studies to map out the frequency of the changes we observed in other astronauts, and other organisms, that go into space, and also to see if the degree of change was similar for shorter missions.

That brings us to a new package of research that builds on the Twins Study, reanalyzing some of the original data with new techniques and providing comparisons with other astronauts. In a set of 19 studies published today in a slew of different journals (along with 10 preprints still under peer review), researchers like Mason (a senior author on 14 of the papers) studied the physiological, biochemical, and genetic changes that occurred in 56 astronauts (including Kelly) who have spent time in spacethe largest study of its kind ever conducted.

The new papers, which incorporate results from cell-profiling and gene-sequencing techniques that have become easier to run only recently, reveal that there are some features of spaceflight that consistently appear in humans, mice, and other animals when they go to space, says Mason. There appears to be a core mammalian set of adaptations and responses to the rigors of spaceflight.

The researchers highlightsix biological changesthat occur in all astronauts during spaceflight: oxidative stress (an excessive accumulation of free radicals in the bodys cells), DNA damage, dysfunction of the mitochondria, changes in gene regulation, alterations in the length of telomeres (the ends of chromosomes, which shorten with age), and changes in the gut microbiome.

Of these six changes, the biggest and most surprising one for scientists wasmitochondrial dysfunction. Mitochondria play a critical role in producing the chemical energy necessary to keep cellsand by extension, tissue and organsfunctional. Researchers found irregular mitochondrial performance in dozens of astronauts and were able to broadly characterize these changes thanks to new genomics and proteomics techniques. Afshin Beheshti, a bioinformatician at NASA and senior author of one study, says mitochondrial suppression helps explain how many of the problems astronauts experienced (like immune system deficiencies, disrupted circadian rhythm, and organ complications) are actually holistically related to each other, since they all rely on the same metabolic pathways.

When youre in space, its not just one are or organ thats affected, its the whole body thats affected, says Beheshti. "We started connecting the dots."

Other research homed in on problems observed at the genetic level. The Twins Study showed that Kellys telomeres got longer in space before shrinking back to normal or even shorter lengths soon after he returned to Earth. Telomeres are supposed to shorten with age, so lengthening makes little sense, and the Twins Study didnt provide enough data to prompt any real conclusions as to why it happened and what the effects were.

Susan Bailey, a Colorado State University expert on telomere research and a senior author for several of the papers, says the new research found that 10 other astronautsexperienced the same telomere lengthening Kelly did irrespective of mission durationas well as the same telomere shrinking once they came back to Earth.

Notably, one of the papers in the new package found that longer telomeres were also associated with climbers of Mount Everest. For Bailey and her colleagues, this suggests that telomere lengthening isaffected by oxidative stresssomething that climbers and astronauts both experience, and that disrupts proper telomere maintenance.

NASA

They are still trying to pinpoint how these pathways work and exactly what the consequences could be (its probably not a secret to longevity), but we now have a foundation to build onwe know what to look for and be aware of in future astronauts on long-duration [and deep space] exploration missions, she says.

Though some of the changes are unexpected, many are no cause for concern. What is amazing to me is how well we adapt to space, says Jeffrey Sutton, director of the Baylor College of Medicines Center for Space Medicine, who was not involved with the new research.Blood cell mutations decreased in Kelly while he was in space(a total surprise for Mason). Astronauts also exhibiteddecreased levels of biomarkers associated with agingandincreased levels of microRNAsthat regulate the vascular systems response to radiation damage and microgravity. One of the strangest findings was that astronauts gut microbiomes managed to bring space microbes found on the ISS back to Earth.

The studies individually and collectively are truly impressive, says Sutton. We have entered a new era of space biomedical research, where the approaches and tools of precision and translational medicine are being applied to advance our understanding of human adaptation to space.

Ultimately, however, the data highlights just how much havoc and stress even the healthiest bodies face during space missionswhich should have an impact on planning for longer missions. I dont think were close to sending untrained people into space for really long periods of time, says Scott Kelly.

Physiologically, he thinks its probably safe to send people to Mars and back. In the distant future, however, instead of going to Mars, were going to be going to the moons of Jupiter or Saturn, he says. Youre going to be in space for years. And at that point, well have to take a closer look at artificial gravity as a mitigation. I wouldnt want to be arriving on the surface of another planetary body and not be able to function. A year or so is workable. Several years probably isnt.

NASA

Were still far away from having to evaluate those kinds of risks. Mason and his colleagues suggest that there should be pharmacological strategies for reducing the impact of gravity on the bodies of returning astronauts.

Sutton believesprecision medicinecould play a huge role in tailoring those drugs to protect astronauts against the effects of microgravity and radiation. And the shared biological responses between astronauts and Mount Everest climbers suggest that some interventions used to protect extreme sports athletes from oxidative stress could be applied to astronauts too.

What we need is more dataand more populations to use for comparison. Mason, Bailey, and their colleagues are starting to collect cell and gene profiles of more astronauts, especially those going on future year-long missions. They also want to study people whove experienced other conditions similar in some way to spaceflight, such as radiotherapy patients, pilots, and flight attendants.

The more we know about the health effects of long-duration spaceflight, the better able we will be to help maintain the health and performance of astronauts during and after spaceflight, says Bailey. Such knowledge benefits those of us on Earth as wellwe are all concerned about getting older, and being in poor health.

This post has been updated with comments from Afshin Beheshti.

Read this article:
Spaceflight does some weird things to astronauts bodies - MIT Technology Review

Read More...

Genetics and Alcohol Use Disorder: 5 Things You Should Know – Longevity LIVE

Saturday, November 7th, 2020

The Penn Medicine team identified 18 genetic variants that are related to either heavy alcohol consumption, alcohol use disorder, or both. Five of these variants overlapped, while eight were associated solely with heavy alcohol consumption. Another five were traced with alcohol use disorder only.

One finding from the study was that, although heavy drinking is a prerequisite for alcoholism, variants for particular genes may predispose someone towards alcoholism. Examples of gene variants cited by the Penn Medicine researchers are DRD2 and SIX3. This finding is important because identifying these gene variants in a person may help medical professionals better ascertain their risk for alcohol use disorder.

Ultimately, paying attention to the genetic aspect of a persons alcohol use disorder may contribute to their treatment. There are ongoing studies about patients receptiveness to certain medications for treatment, based on their genes.

For example, naltrexone is a drug thats commonly used to treat dependence on alcohol, as well as opiates. In research cited by the NIAAA, it was found that patients with a specific gene variation responded positively to naltrexone treatment. Those who didnt have the gene, however, did not. In the future, this kind of information may factor into the accuracy and responsiveness of medical treatment for alcohol addiction.

Conclusion: Unlocking Important New Knowledge about Genetics and Alcohol Addiction

Though the relationship between genes and alcoholism has been under scrutinous scientific study for some time, it isnt always common knowledge to laymen. But not being able to see the bigger picture of what contributes to alcoholism may allow certain myths about it to prevail. Many people may still believe that alcohol addiction is 100% a personal choice. But as the information above about genetics and alcohol use disorder portray, its never that simple.

In any case, whether genes influence someones predisposition to alcohol use disorder, no attempt at healing from it is a futile one. Be both compassionate and knowledgeable when approaching the issue of alcoholismbecause your support could save a life.

The rest is here:
Genetics and Alcohol Use Disorder: 5 Things You Should Know - Longevity LIVE

Read More...

Adrenomyeloneuropathy Treatment Market Covid-19 Impact On In-depth Industry Analysis: Ascend Biopharmaceuticals, Immatics Biotechnologies, Human…

Saturday, November 7th, 2020

The report on the Global Adrenomyeloneuropathy Treatment Market has been prepared after conducting a comprehensive research through a systematized methodology. These skills are useful for scrutinizing the market on the terms of outlined research guidelines. Mainly, global Adrenomyeloneuropathy Treatment market research report covers all the information about the target audience, manufactures, vendors, research papers, products and many more. Keeping a focus on the overall market aspects, and perceptions, this report vastly covers profiles of the companies who have made it big in this particular field along with their sales data and other data. It also suggests the business models, innovations, growth and every information about the big manufacturers that will be present the future market estimates. Every market consists of set of manufacturers, vendors and consumers that gives a definition to the market, its each and every move, achievements. All these are the important subjects required to study the analysis of the global Adrenomyeloneuropathy Treatment market.

Get sample copy of Adrenomyeloneuropathy Treatment Market report @ https://www.orbispharmareports.com/sample-request/44669

It also includes the major market conditions across the globe such as the product profit, price, production, capacity, demand, supply, as well as market growth structure. In addition, this report offers significant data through the SWOT analysis, investment return data, and investment feasibility analysis. The global Adrenomyeloneuropathy Treatment market report also features a comprehensive quantitative and qualitative evaluation by analysing information collected from market experts and industry participants in the major points of the market value chain.

Major Company Profiles operating in the Adrenomyeloneuropathy Treatment Market:

Ascend BiopharmaceuticalsImmatics BiotechnologiesHuman LongevityNovadip BiosciencesBioRestorative TherapiesEureka TherapeuticsCytori TherapeuticsAllogene TherapeuticsRegeneusNewLink GeneticsTalaris Therapeutics

By the product type, the market is primarily split into:

Steroid Replacement TherapyStem Cell Transplant

By the application, this report covers the following segments:

HospitalsClinicsAmbulatory Surgical CentersOthers

The data offered in global Adrenomyeloneuropathy Treatment market report is gathered based on the latest industry news, trends, as well as opportunities. This study offers a separate analysis of the major trends in the existing market, mandates and regulations, micro macroeconomic indicators is also comprised in this report. By doing so, the study estimated the attractiveness of every major segment during the prediction period.

Browse the complete report @ https://www.orbispharmareports.com/covid-19-impact-on-2020-2026-global-and-regional-adrenomyeloneuropathy-treatment-industry-production-sales-and-consumption-status-and-prospects-professional-market-research-report-standard-version/

Moreover, the report comprises the analysis of opportunities available in the Adrenomyeloneuropathy Treatment market on the global level. It also includes the major market conditions across the globe such as the product profit, price, production, capacity, demand, supply, as well as market growth structure. The annual progression for the global Adrenomyeloneuropathy Treatment market in different regions cannot always be listed down as it will keep changing, thus studying and reviewing markets occasionally becomes vital.

In addition, the Adrenomyeloneuropathy Treatment market report provides a detailed information about the key market players along with the strategies they implemented to gain market existence and develop themselves. The report includes precise market estimations depending on current market status and future market forecasts.

For Any Query on the Adrenomyeloneuropathy Treatment Market: https://www.orbispharmareports.com/enquiry-before-buying/44669

About Us :

At Orbispharma we curate the most relevant news stories, features, analysis and research reports on the important challenges undertaken by the pharmaceutical and related sectors. Our editorial philosophy is to bring you sharp, focused and informed perspective of industries, the end users and application of all upcoming trends into the pharma sector. Orbispharma believes in conversations that can bring a change in one of the most crucial economic sectors in the world. With these conversations we wish our customers to make sound business decisions with right business intelligence.

Contact Us :

4144N Central Expressway,Suite 600, Dallas,Texas 75204, U.S.A.+1 (972)-362-8199[emailprotected]

See original here:
Adrenomyeloneuropathy Treatment Market Covid-19 Impact On In-depth Industry Analysis: Ascend Biopharmaceuticals, Immatics Biotechnologies, Human...

Read More...

Global AI Medicine Software Market Analysis of Key Players, Type, Application, Demand and Consumption By 2026 – Stock Market Vista

Saturday, November 7th, 2020

There are millions of them around the globe waiting for clutching on to some of the latest vital information circulating across the globe. The up-to-the-minute AI Medicine Software market report based on the growth and the development of theAI Medicine Software marketis systematically listed down. The AI Medicine Software market report comprises statistically verified facts such the unique essence including topological investigations, worldwide market share, government stringent norms, applications, current trends, futuristic plans, market bifurcations, and so on mentioned in a crystal clear pattern.

The statistical plus scientific AI Medicine Software market report has all the important market aspects penciled down in a layman language format so that the data based on the markets productivity or future strategy can be easily extrapolated from the reports. The AI Medicine Software market report has the dominant market players Tempus Labs, Inc., Flatiron Health, Inc., Gene42, Inc., Sunquest Information Systems Inc, 2bPrecise LLC, NantHealth, Inc, IBM Watson Group, Human Longevity, Inc., N-of-One, Inc., Translational Software, Inc, SOPHiA GENETICS SA, Syapse, Inc., LifeOmic Heal explained in detail.

Sample of global AI Medicine Software Market Report at::https://www.marketresearchstore.com/report/global-ai-medicine-software-market-report-2020-industry-761259#RequestSample

The essential futuristic segments such as {Machine Learning, Natural Language Processing, Others}; {Drug Discovery, Precision Medicine, Others} have also been detailed out in the AI Medicine Software market report for the clients convenience and more of vital data embracing capability. The forecast trends along with the current market status can better understand the AI Medicine Software market development on a global basis. The intricate industrial strategies and the supply-demand chain are also discussed in the contextual report.

Key points of the global AI Medicine Software market

Theoretical analysis of the global AI Medicine Software market stimulators, products, and other vital facets Recent, historical, and future trends in terms of revenue and market dynamics are reported Pin-point analysis of the competitive market dynamics and investment structure is predicted to grow Future market trends, latest innovations, and various business strategies are reported Market dynamics include growth influencers, opportunities, threats, challenges, and other crucial facets

The AI Medicine Software market report has the imperative data mentioned in a systematic way only after comprehensive inspection and vigilant referencing. The diagrammatic representations such as a pie chart of the AI Medicine Software market are also drawn out so as to attract the punters and make it easy for them to comprehend the entire AI Medicine Software market from in and out. The most eye-catching format of the AI Medicine Software market report is its market bifurcation based on the product type, application, geography, end-users, and more as per the particular market. The geographical segments Europe, North America, Latin America, Asia Pacific, and Middle East & Africa are further exhaustively mentioned.

Read Detailed Index of full Research Study at::https://www.marketresearchstore.com/report/global-ai-medicine-software-market-report-2020-industry-761259

Questions answered in the report include

1. What is the expected market size by the end of the forecast period?2. What are the major factors initiating the global AI Medicine Software market growth?3. What are the latest developments and trending market strategies that are influencing the growth of the AI Medicine Software market?4. What are the key outcomes of the AI Medicine Software market developments?5. Who are the key players in the market?6. What are the opportunities and challenges faced by the key players?

The AI Medicine Software market report endows the global market dominance, market segmentation, growth factors, and others reported such that the clients can have a total tour of the market without any much off efforts needed.

Key Reasons for Purchasing Global AI Medicine Software Market Report

New approaches and latest development trend that describe the structure of the market Advanced market breakdown structure Historical data and future market scope In-depth market analysis based on statistics, growth stimulators, and market developments Statistical data representation through figurative, numerical, and theoretical elaboration Report provides insight of the business and sales activities

Ask Any Kind of Query Before Purchasing the Report Here:https://www.marketresearchstore.com/report/global-ai-medicine-software-market-report-2020-industry-761259#InquiryForBuying

View post:
Global AI Medicine Software Market Analysis of Key Players, Type, Application, Demand and Consumption By 2026 - Stock Market Vista

Read More...

Global Obesity Treatment Market Incredible Potential Examined in New Research Report – The Think Curiouser

Saturday, November 7th, 2020

Global Obesity Treatment Market: Overview

Obesity is a disorder in which excess body fat gets accumulated to such extent that it may have negative effects on health. It occurs over time when people eat more calories than they utilize. The reasons for obesity can be medical problems, inactivity, genetics, family lifestyle, unhealthy diet, medications, age, and pregnancy. Being obese increases the risk of diabetes, heart disease, stroke, arthritis, and some type of cancers.

Obesity treatment basically incorporates a two-step process: assessment and management. Obesity assessment includes determination of the level of obesity and obesity management involves overall maintenance of body weight as well as the systematic weight loss programs.Government initiatives to increase the awareness about fitness, technological advancements improving the compliance rates of surgeries, and aggressive marketing strategies to attract customers are some of the drivers for the growth of the obesity treatment market.

Factors responsible for restraining the growth of the obesity treatment market are availability of low cost alternatives, high cost of customization, and post-surgical side effects.

Request Brochure for Report

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=18497

Global Obesity Treatment Market: Notable Developments

The obesity treatment market is segmented based on lifestyle changes, surgical & implant devices, and medication therapy. Lifestyle changes involves dietary changes and exercise. The dietary segment held a significant share in 2015 and is expected to increase during the forecast period. The reasons for the projected growth of the segment might be low cost of therapy, increase in health consciousness among people, and acceptance of the fact that it is easier to lower calorie intake to a greater degree than to burn more calories through increased exercise.

The surgery & implant devices are further categorized into gastric bypass surgery, gastric balloon, gastric band, electrical stimulation system, and gastric emptying system. Gastric bypass surgery is a fast growing segment in the obesity treatment market owing to factors such as fast recovery time, improved psychological status, and improved longevity. The minimally invasive segment is expected to grow at a higher rate during the forecast period due to its reversible nature, rapid effect, and cost & time effectiveness. It basically involves employing the implant devices in gastric area, which minimizes the incidences of post-operative infections that arise from invasive procedures. It in turn shortens the hospital stays for patients.

Request for Analysis of COVID19 Impact on Obesity Treatment Market:

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=18497

Global Obesity Treatment Market: Key Trends

The surgery & implant devices are further categorized into gastric bypass surgery, gastric balloon, gastric band, electrical stimulation system, and gastric emptying system. Gastric bypass surgery is a fast growing segment in the obesity treatment market owing to factors such as fast recovery time, improved psychological status, and improved longevity. The minimally invasive segment is expected to grow at a higher rate during the forecast period due to its reversible nature, rapid effect, and cost & time effectiveness. It basically involves employing the implant devices in gastric area, which minimizes the incidences of post-operative infections that arise from invasive procedures. It in turn shortens the hospital stays for patients.

In medication therapy, the individual (satiety) drug and combination drug therapy are the two major segments. The combination drug segment in the obesity treatment market captured a large share globally in 2015. It is mainly attributed to the synergistic effect of combined therapy in obesity treatment and rising prevalence of obesity. The satiety drug which provide a feeling of gastric fullness is a fast growing segment in the obesity treatment market. The major reason for the growth is its cost which is lower than that of the combination therapy.

Key Players of Obesity Treatment Market Report

Key market players operating in the obesity treatment market include NutriSystem, Inc. (U.S.), Kellogg Company (U.S.), Ethicon, Inc. (U.S.), Atkins Nutritionals, Inc. (U.S.), Herbalife Ltd. (U.S.), Covidien plc (U.S.), Apollo Endosurgery (U.S.), Amer Sports (Finland), Johnson Health Technology, Ltd. (Taiwan), Cybex International (U.S.), Olympus Corporation (Japan), Brunswick Corporation (U.S.), and Technogym SpA (Italy). Increase in focus of the market players on gaining FDA approvals to launch new drugs and devices in the obesity treatment market propels the growth of the obesity treatment market exponentially during the forecast period.

Buy Obesity Treatment Market Report

https://www.transparencymarketresearch.com/checkout.php?rep_id=18497&ltype=S

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

Continued here:
Global Obesity Treatment Market Incredible Potential Examined in New Research Report - The Think Curiouser

Read More...

Global Adrenomyeloneuropathy Treatment Market Size, Share, Trends, CAGR by Technology, Key Players, Regions, Cost, Revenue and Forecast 2020 to 2025 -…

Saturday, November 7th, 2020

New Market Research Report: on Adrenomyeloneuropathy Treatment Market size | Segment by Applications (Hospitals, Clinics, Ambulatory Surgical Centers and Others), by Type (Steroid Replacement Therapy and Stem Cell Transplant), Regional Outlook Opportunity, Market Demand, Latest Trends, Adrenomyeloneuropathy Treatment Industry Share & Revenue by Manufacturers, Leading Companies Profiles, Analysis, Growth Forecast 2025. Analyzes current market size and upcoming Few years' growths of this industry.

Adrenomyeloneuropathy Treatment Market Size report is the best source that gives CAGR values with variations during the forecast period of 2020-2025 for the market. The study encompasses market drivers and restraints by using SWOT analysis, along with their impact on the demand over the forecast period. This global market report endows with a profound overview of product specification, product type, production analysis, and technology by taking into consideration the major factors such as revenue, cost, and gross margin. The Adrenomyeloneuropathy Treatment advertising report has been prepared based on the market type, size of the organization, availability on-premises, and the end-users organization type.

Some of the prominent players operating in the global Adrenomyeloneuropathy Treatment market include Ascend Biopharmaceuticals, Immatics Biotechnologies, Human Longevity, Novadip Biosciences, BioRestorative Therapies, Eureka Therapeutics, Cytori Therapeutics, Allogene Therapeutics, Regeneus, NewLink Genetics and Talaris Therapeutics among others.

Request Sample Copy of this Report @ https://www.express-journal.com/request-sample/240610

Competitive Analysis: Adrenomyeloneuropathy Treatment Market

Global Adrenomyeloneuropathy Treatment market Size is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Adrenomyeloneuropathy Treatment market Share for global, Europe, North America, Asia-Pacific, South America, and Middle East & Africa.

Global Adrenomyeloneuropathy Treatment Market Split by Product Type and Applications:

Based on Types:

Based on Application:

The latest research on the Adrenomyeloneuropathy Treatment Market Size fundamentally delivers insights that can empower stakeholders, business owners, and field marketing executives to make effective investment decisions driven by facts and extremely thorough research. The study aims to provide an evaluation and deliver essential information on the competitive landscape to meet the unique requirements of the companies and individuals operating in the Adrenomyeloneuropathy Treatment Market for the forecast period, 20202025. To help firms comprehend the Adrenomyeloneuropathy Treatment industry in multiple ways, the report exhaustively assesses the share, size, and growth rate of the business worldwide.

Report Highlights:

The report covers the shifting industry dynamics

Detailed information about the market segmentation

Covers past, present and projected industry size Recent industry trends

Key Competition landscape

Business strategies of key players and product offerings

Potential and niche segments/regions exhibiting promising growth

A neutral perspective towards market performance

Queries Resolved In This Report:

Which will be the specialties at which Adrenomyeloneuropathy Treatment Market players profiling with intensive designs, financials, and ongoing headways should set nearness?

Which will be the foreseen development rates for your own Adrenomyeloneuropathy Treatment economy out and out and each portion inside?

Which will be the Adrenomyeloneuropathy Treatment application and sorts and estimate joined intently by makers?

Which will be the dangers which will attack growth?

The length of the global Adrenomyeloneuropathy Treatment market opportunity?

How Adrenomyeloneuropathy Treatment Market share advance vacillations of their value from various assembling brands?

Chapters Define in TOC (Table of Content) of the Report:

Chapter 1: Market Survey, Drivers, Restraints and Good fortune, Segmentation overview

Chapter 2: Market competitiveness by Manufacturers

Chapter 3: Production by Regions

Chapter 4: Consumption by Regions

Chapter 5: Production, By Types, Revenue and Market share by Types

Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications

Chapter 7: Overall profiling and analysis of Manufacturers

Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses

Chapter 9: Supply Chain, Sourcing Strategy and Downstream Buyers

Chapter 10: Marketing Strategy Analysis, Distributors/Traders

Chapter 11: Market Influence Factors Analysis

Chapter 12: Market Predict

Chapter 13: Adrenomyeloneuropathy Treatment Research Findings and Conclusion, Appendix, methodology and data source

Request Customization on This Report @ https://www.express-journal.com/request-for-customization/240610

Go here to see the original:
Global Adrenomyeloneuropathy Treatment Market Size, Share, Trends, CAGR by Technology, Key Players, Regions, Cost, Revenue and Forecast 2020 to 2025 -...

Read More...

Early Evidence Shows Fasting, Keto Diet May Make Chemo and Some Other Cancer Treatments More Effective and Easier to Tolerate – Curetoday.com

Saturday, November 7th, 2020

Jocelyn Aguilar felt bad enough after the first of a scheduled four rounds of chemotherapy that she thought about quitting.

She had no detectable cancer after undergoing double mastectomy for breast cancer, so the chemotherapy was an optional treatment that Aguilar, age 37 when diagnosed in October 2019, had chosen to reduce the risk of recurrence.

She ultimately decided to continue because, starting with her next round of chemotherapy, she was going to help test a counterintuitive-but-promising strategy for reducing chemotherapys side effects and increasing its cancer-fighting power: a very low-calorie diet designed to mimic the effects of fasting.

On weeks (when) I was due to receive chemo that Friday, I got four boxes of food labeled Tuesday, Wednesday, Thursday and Friday. The only food I ate those days came from that days box. On Saturday morning, I woke up and eased myself back into normal eating, says Aguilar, a nurse who works at the University of Southern California (USC), where the trial took place.

The pain I experienced with that first round of chemo, before the fasting, was so terrible that I didnt think I could go on, says Aguilar, who described the sensation as aches and pains all over her body. With the fast, there were still some effects, but they were not nearly as bad. It was a huge difference.

Aguilar says that her food boxes each contained about 300 calories worth of plant-based food. The diet is billed by its distributor as containing micro- and macronutrients that are nourishing but not recognized as food by the body, which mimics fasting.

Its hard to imagine a more counterintuitive cancer treatment than fasting why deprive the body of vital nutrients when it would seem to need them most? but a growing body of research suggests that fasting decreases the toxicity of cancer treatments and may increase their efficacy too.

Some evidence also shows that a ketogenic diet, which deprives the body of carbohydrates rather than all calories, may increase the efficacy of some cancer treatments. In fact, there is even some thought that the two diets may help prevent cancer, although evidence for this is currently limited.

When it comes to supplementing cancer therapies, the benefits of either dietary intervention also have yet to be definitively proven unless youre a mouse. The animal data for fasting, which started in our lab but is now coming from many labs, is extraordinary. Its hard to think of anything in the past, ever, that has done better, says Valter Longo, who holds a doctorate in biochemistry and is the Edna M. Jones Professor of Gerontology and Biological Sciences and the director of the Longevity Institute at the USC Leonard Davis School of Gerontology.

Healthy cells and tumor cells respond differently to fasting. Healthy cells shut down their growth-promoting pathways shortly after the food stops coming in and focus on cell repair. Cancer cells, on the other hand, rarely slow their unrestrained growth enough to engage in this self-protective behavior.

Fasting thus increases the ability of healthy cells to withstand stressors such as chemotherapyor radiotherapy, but it leaves cancer cells, which suddenly have less nutritional support to sustain their rapid growth, unusually weak and vulnerable.

Fasting also depletes stored carbohydrates. Normal cells can adapt to this by running mostly on two fat-derived energy sources fatty acids and ketones but cancer cells are far more reliant on sugars, starches and the insulin that drives them into cells.

Most of the mouse studies to date have assessed fastings effect on chemotherapy or radiotherapy, but at least one study has found that a low-calorie fasting- mimicking diet (FMD) plus simple vitamin C can slow the progression of KRAS-mutated colon cancer. Another study, this one published in the prestigious journal Nature, found that both fasting and a FMD increased and extended the efficacy of the hormonal treatments tamoxifen and Faslodex (fulvestrant) in mouse models of hormone-receptor-positive breast cancer.

The first clinical trial of short-term fasting in humans, which was published in 2009, reported results in 10 patients with various types of cancer. It found that fasting reduced chemotherapy-related toxicities fatigue, weakness and gastrointestinal side effects in the six patients who fasted 48 to 140 hours before and five to 56 hours after some (but not all) of their chemotherapy sessions.

Several other trials in humans, all of them following small patient populations for short periods of time, have also found that fasting reduced treatment-related toxicities such as fatigue or DNA damage in healthy cells. For example, one Dutch trial assigned six patients with breast cancer to follow normal dietary guidelines and seven others to fast 24 hours before and after chemotherapy. Nonhematological toxicity did not differ between the two groups, but the researchers found evidence that fasting reduced bone marrow toxicity and reduced chemotherapy-induced DNA damage in some healthy blood cells.

Data from several of these small trials also suggested that fasting increased treatment efficacy, but none of them were large enough (or lasted long enough) to prove that fasting extended patients survival. There is even less evidence to support the use of fasting or the ketogenic diet in combination with immunotherapy treatments, although that remains a tantalizing possibility.

The only large trial in humans to have reported results so far was inconclusive for a somewhat unexpected reason.

Investigators randomly assigned 131 Dutch women, all of whom were slated to receive chemotherapy for stage 2/3 HER2-negative breast cancer, either to eat according to standard guidelines or to follow the FMD. Sixty-six of the women were assigned to follow the FMD but, unfortunately, so few actually complied that it was impossible to evaluate the diets effects. Just 32% of women in the fasting group fasted before at least half of their chemotherapy cycles, and just 24% of them fasted before all of them.

Patient noncompliance was particularly disappointing because the FMD was designed by Longo who has a financial interest in a company that sells FMD meal kits as a less demanding way to get all the effects of a true, zero-calorie fast.

It wasnt easy, says Aguilar, but it was doable. Im not normally a healthy eater, and I was being given steroids at the time, so my appetite was out of control, but I still managed it because it reduced the pain so much.

Hopefully, patients in several other large studies, all of which are nearing their scheduled completion dates, will comply with fasting protocols well enough to help researchers determine whether short-term fasting can extend life, reduce treatment toxicity or both for patients with glioblastoma, non-small cell lung cancer, lung adenocarcinoma, ovarian cancer, breast cancer and colorectal cancer.

Positive results could change standards of care for all those tumor types within the next couple of years.

For patients who cant wait that long to select their treatment plan, the obvious question is whether they should ask their oncologists about starting now with short- term fasts or the FMD.

Some experts believe its too early to use fasting anywhere outside of clinical trials.Indeed, a group of Italian clinicians recently published a letter in Nature Reviews Cancer that cautioned against what they perceive as excessive enthusiasm about fastings potential benefits and insufficient caution about its potential to harm some patients.

It is worrying that the application of fasting in oncology has been prematurely reported by the media as a potential advance in medical oncology, to the point where FMD kits have recently been commercialized, the clinicians wrote. These may negatively interfere with cancer care, as patients at risk of malnutrition or sarcopenia (muscle loss) could autonomously decrease protein-calorie intake during treatment.

Longo agrees that neither malnourished patients nor those who are responding to their current treatment should try fasting or the FMD outside of clinical trials. However, he believes the data from both animal models and early human trials are strong enough to make fasting an option when approved treatments stop working.

I think (the evidence so far) is enough for an oncologist to say, Look, your therapy isnt working. Im out of options here. This fasting-mimicking diet is so effective in mice. Why dont we give it a shot? You have to understand there are risks, but you also have to understand that were out of options. That conversation would be appropriate now, Longo says.

Fasting isnt the only way to drive blood sugar and insulin down. Patients can achieve nearly equivalent reductions by following a ketogenic diet that provides about 80% of calories from fat, 12% from protein and 8% from carbohydrates.

Low sugar consumption means low blood sugar, which, in turn, means low levels of insulin a hormone secreted by the pancreas to drive sugar into muscles and fuel their growth and/or activity. Healthy tissue, as mentioned before, can adapt to deriving nearly all its energy fromfat, although many people feel pretty drained for a week or so at the beginning of that adjustment. (This lousy feeling is known as keto flu.) Many tumors, on the other hand, seem far less able to overcome their dependence on insulin and sugar (aka glucose).

Weve known for 100 years that cancer cells take up glucose at a much higher rate than do the normal tissues from which those cancer cells emerge, says Lewis Cantley, who holds a doctorate in biophysical chemistry and is the Meyer Director of the Sandra and Edward Meyer Cancer Center and a professor of cancer biology in medicine at Weill Cornell Medical College.

This does not mean that patients can starve their tumors to death simply by following ketogenic diets, but it has led many researchers to speculate that adding a ketogenic diet to standard treatment protocols might increase the efficacy of many of those regimens.

It has been difficult to test this theory, however. Because no pharmaceutical company canpatent a ketogenic diet, no one has a financial incentive to spend the millions of dollars that largestudies cost. Instead, studies get funded through the National Institutes of Health and foundation grants. Tests of FMDs face the same issue.

The ketogenic diet also runs into the same problem that makes it hard to test fasting: patient compliance. Indeed, researchers who work for the Department of Veterans Affairs in Pittsburgh enrolled 11 patients with cancer in a 16-week trial of the ketogenic diet. Only four of them actually followed the diet all 16 weeks.

In spite of the challenges, several recent discoveries suggest that ketogenic diets may be particularly helpful for certain cancer treatments helpful enough to drive funding and convince patients to follow the diet.

Cantley discovered a previously unknown link between sugar, insulin and cancer growth more than three decades ago: an enzyme called phosphoinositide 3-kinase (PI3K) that helps drive sugar into cells. Mutations in the genes that regulate PI3K causing an increase in PI3K activity are among the most common of all cancer mutations.

His discovery eventually led to the creation of PI3K- inhibiting medications, three of which have been approved for the treatment of several cancers. But all three have a big drawback.

When you give patients a PI3 kinase inhibitor, which hits the same enzyme that propagates the insulin response, you get the unsurprising result that the patient instantly becomes insulin resistant. Many of the patients in the trials of these drugs had to drop out because of high blood sugar, Cantley says.

Extra insulin, whether created by the body in response to rising blood sugar or deliberately injected, will solve the problem by driving the sugar into muscles, but it also drives sugar into tumors and destroys treatment efficacy.

Cantleys team hypothesized that PI3K inhibitors would be far safer and more effective if used in combination with some tool that would control blood sugar without driving it into tissues. They saw dramatically improved results in mice when they paired PI3K inhibitors with a class of diabetes medications called SGLT2 inhibitors, which reduce the bodys absorption of glucose via the kidneys so that excess glucose is excreted through the urine. Results were better still when they fed mice a ketogenic diet.

Blood sugar levels hardly went up. Insulin levels hardly went up. Tumors melted away, says Cantley, who also has a financial interest in a company that makes prepackaged meals for patients with cancer. Every tumor we tried essentially disappeared whenever we gave a PI3 kinase inhibitor with a ketogenic diet.

A large human trial will compare the current standard for using PI3K inhibitors against treatment plans that combine PI3K inhibitors with either SGLT2 inhibitors or a ketogenic diet. The ongoing global pandemic delayed the trial for several months, but enrollment has now begun.

And its not the only trial thats testing the ketogenic diets effect on cancer treatments. At least 18 other such studies are either recruiting patients or preparing to do so.

The whole thing comes down to energy. Without energy, nothing can grow, says Thomas N. Seyfried, who holds a doctorate in genetics and biochemistry and is a biology professor at Boston College who studies how metabolic therapies such as a ketogenic diet can affect cancer and other diseases. Tumor cells make energy by fermenting glucose and the amino acid glutamine. If we restrict the availability of glucose and glutamine, this will create tremendous metabolic stress on the tumor cells.

For more news on cancer updates, research and education, dont forget tosubscribe to CUREs newsletters here.

Read more:
Early Evidence Shows Fasting, Keto Diet May Make Chemo and Some Other Cancer Treatments More Effective and Easier to Tolerate - Curetoday.com

Read More...

Healthcare Business Process Outsourcing Market 2020 Global Forecasts Analysis, Company Profiles, Competitive Landscape and Key Regions 2025 – Zenit…

Saturday, November 7th, 2020

Researchmoz Presents Healthcare Business Process Outsourcing Market Size, Status and Forecast 2020-2026 New Document to its Studies Database

This report, which has been published, is having a meaningful Healthcare Business Process Outsourcing market insight. It casts some lights on industry products and services. Along with those product applications, it also examined whether it reaches up to the end-users or not. This report on this Healthcare Business Process Outsourcing market has given an overall view of the recent technologies used and technological improvements. It also focuses on recent industry trends and which products are quite demanding from a customers perspective. This report is focused on every aspect of the forecast year 2026.

Healthcare Business Process Outsourcing Market dynamics analysis

This report is representing a whole market scenario on a global basis. In this report, we can also find the analysis growth of industries. Through this report, we can easily interpreter the level of market competition, different pricing models, the latest market trends, customer demand, etc. This report acknowledges the revenue model and market expansion of this Healthcare Business Process Outsourcing market. If you want to get that full market information, then this report can help you. It also gives a comprehensive knowledge about the demand and supply graph. Suppose that demand curves moved downward, then from this report, you can know about those factors responsible for its decline. Accordingly, you can know the responsible factors for the rising curve. This Healthcare Business Process Outsourcing market report gives a total knowledge about the market trend and improves its strategies and pricing model.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.researchmoz.com/enquiry.php?type=S&repid=2812408&source=atm

In the competitive analysis section of the report, leading as well as prominent players of the global Genomic Biomarker market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.The key players covered in this studyBio-RadBeckman CoulterMyriad GeneticsThermo Fisher ScientificRocheQIAGENEpigenomicsAlmacPfizerHuman LongevityValiRxPersonalisEagle GenomicsEmpire GenomicsAgilentIllumina

Research and Methodology

For the research, the Healthcare Business Process Outsourcing markets research teams are adopted various high-end techniques. Industry best analysts are worked on this report. They collected data from various reliable sources and have taken samples of different market segments. They utilize both qualitative and quantitative data in this report. All data are based on primary sources, which are focused on the assessment year 2020-2026. For wise decision-making, they have also done SWOT analysis, which can also help them know their predicted future results. This report also helps to develop Healthcare Business Process Outsourcing market growth by improvising its strategic models.

segment by Type, the product can be split intoOncologyCardiologyNeurologyNephrology

Market segment by Application, split intoHospitalsDiagnostic and research laboratories

Based on regional and country-level analysis, the Genomic Biomarker market has been segmented as follows:North AmericaUnited StatesCanadaEuropeGermanyFranceU.K.ItalyRussiaNordicRest of EuropeAsia-PacificChinaJapanSouth KoreaSoutheast AsiaIndiaAustraliaRest of Asia-PacificLatin AmericaMexicoBrazilMiddle East & AfricaTurkeySaudi ArabiaUAERest of Middle East & Africa

Regional and Country-level Analysis

The Healthcare Business Process Outsourcing market is analysed and market size information is provided by regions (countries).

The key regions covered in the Healthcare Business Process Outsourcing market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2812408&licType=S&source=atm

Table Of Content Covered In this Healthcare Business Process Outsourcing Market Report:

1 Report Overview

2 Global Growth Trends by Regions

3 Competition Landscape by Key Players

4 Breakdown Data by Type (2015-2026)

5 Breakdown Data by Application (2015-2026)

6 North America

7 Europe

8 China

9 Japan

10 Southeast Asia

11 India

12 Central & South America

13Key Players Profiles

14Analysts Viewpoints/Conclusions

NOTE : Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details

Read the original:
Healthcare Business Process Outsourcing Market 2020 Global Forecasts Analysis, Company Profiles, Competitive Landscape and Key Regions 2025 - Zenit...

Read More...

Turning the Tide – Lifestyle Medicine and change (part 7) – South Coast Herald

Sunday, October 25th, 2020

Last week we presented common excuses given for why we dont want to commit to changing our behaviour and adopting a healthier way of living.

Today we will cover more ground.

It is true. There are some people who live the most atrociously unhealthy lives who seem to fly under the radar, and escape the bullets. In spite of all odds, they make it to a ripe old age. Good luck to them. But the chance you will do likewise is remote.

ALSO READ : Turning the Tide Top tips on how to change your diet for the better

There are many factors that may have contributed to his longevity genetics, a more active younger life, getting enough sleep at night, a positive attitude towards life, eating some natural whole foods, even if it is a tin of baked beans from time to time. One gets these outliers, who beat the odds.

But instead of stacking up the odds against you, why not try to reduce the risks by whittling away at factors that have been scientifically proven to reduce your health and vitality. And in the process you can reap the rewards of feeling so much better within days of adopting change.

I agree it can be confusing. Author Michael Pollan said Eat food, not too much, mostly plants. Too much of what we eat is food-like substances highly processed edible concoctions that have a long list of very scientific-sounding ingredients. The best foods are the ones that dont have ingredient lists the ones you buy in the vegetable and fruit sections of the supermarket. For thousands of years humankind has thrived on natural foods fruits, vegetables, whole grains, legumes and nuts, seeds and spices. It is only in the last century that the industrial revolution has introduced factory-altered foods to make them more palatable, addictive and provide a longer shelf-life. In doing so our food has lost a great deal of the natural goodness fibre, phytochemicals, vitamins, minerals, etc.

His second point is also relevant not too much. When the food has been so concentrated and titillated, it is easy to over-indulge, resulting in excessive energy intake. This is one of the main reasons for the obesity epidemic.

If we eat mostly plants, we will not be exposed to high levels of saturated fats, and excessive proteins, heme-iron, inflammatory stimulators, hormones and growth stimulators so rife in animal products.

The media loves controversy it sells newspapers/magazines. We love to get good news about our bad habits.

So when some study or article makes claims that support peoples bad habits, even when the study has been sponsored by the industries who benefit most from the recommendations, the headlines are all over the place, creating confusion and controversy. There is more than enough very sound research supporting the simple nutritional information we present in this blog, and which has become imbedded in most of the national guidelines around the world.

There are very many challenges in life. If we want to achieve anything worthwhile we have to make sacrifices and overcome barriers. No success comes easily.

A healthy body, a clear mind, energy for living, and freedom from so many of the scourges of modern life require persistence in small, sustainable changes. We should start slowly, but gradually stretch the limits of our capabilities. You may have pain walking or jogging, but you can strengthen your upper body and torso; you may be able to swim with freedom of pain, or cycle. Where theres a will, theres a way. You may need to counsel with a physiotherapist or a personal trainer, but there are ways you can improve your physical activity.

I hope that the answers you have read to some of the common excuses has given you opportunities to reassess your commitment to change, and think creatively about how you can begin to enjoy the benefits of positive health changes.

Next week we will discuss the SMART pneumonic for implementing changes whether they be with exercise, or dietary changes, or stopping smoking, or dealing with stress in your life.

Until then, contemplate about what you want out of life.

Dave Glass

Dr David Glass graduated from UCT in 1975. He spent the next 12 years working at a mission hospital in Lesotho, where much of his work involved health education and interventions to improve health, aside from the normal busy clinical work of an under-resourced mission hospital. He returned to UCT in 1990 to specialise in obstetrics/gynaecology and then moved to the South Coast where he had the privilege of, amongst other things, ushering 7000 babies into the world. He no longer delivers babies but is still very clinically active in gynaecology. An old passion, preventive health care, has now replaced the obstetrics side of his work. He is eager to share insights he has gathered over the years on how to prevent and reverse so many of the modern scourges of lifestyle obesity, diabetes, ischaemic heart disease, high blood pressure, arthritis, common cancers, etc. He is a family man, with a supportive wife, and two grown children, and four beautiful grandchildren. His hobbies include walking, cycling, vegetable gardening, bird-watching, travelling and writing. He is active in community health outreach and deeply involved in church activities. He enjoys teaching and sharing information.

HAVE YOUR SAY

Like the South Coast Heralds Facebook page, follow us on Twitter and Instagram

See the original post:
Turning the Tide - Lifestyle Medicine and change (part 7) - South Coast Herald

Read More...

Biohacking Conference Kyiv about Efficient Health Optimization Techniques to Take Place on November 11 – Interfax-Ukraine

Sunday, October 25th, 2020

In the modern world of rapid technological development, you need to do a lot to be successful and stay in the top. It is especially important to know how to stay healthy and enjoy a fulfilling life, be productive and push yourself beyond limits.

Answers to the most topical questions about upgrading the body and mind will be given at the first Biohacking Conference Kyiv, dedicated to innovative ways of improving health and prolonging youth. Organized by Smile-Expo, the event will take place on November 11, 2020.

Leading experts from various industries will speak at the event: doctors, scientists, gerontologists, biohackers and many others. Among them:

- Oleksandr Kolyada geneticist, research associate at the lab of epigenetics at the Institute of Gerontology, founder of DIAGEN lab.

- Lyudmyla Goncharova dietarian, immunologist, two-time winner of The Battle of Nutritionists TV show on STB, founder of Goncharova Clinic.

- Oleksandr Skorokhod Candidate of Biological Sciences, research worker at the Department of signaling cell systems at the Institute of Molecular Biology and Genetics at the National Academy of Sciences of Ukraine.

- Hlib Khodorovskyi meditation expert, experienced mindfulness trainer.

Experts will delve into the main biohacking tools and explain the interrelation of dieting and longevity. Separately, speakers will discuss how genetic researches help to detect health risks, determine parameters of food digestion, and draw up a disease prevention program. In addition, the reports will focus on a safe approach to sports training, the benefits of mindfulness meditations and health management intended to improve productivity in all areas of life.

About safety measures at the conference

To protect guests, speakers, participants, and sponsors of the event against catching coronavirus, Biohacking Conference Kyiv will adhere to all the requirements of the Ukrainian government and the Ministry of Healthcare aimed to prevent the spread of COVID-19.

The following preventive measures will be taken at event, among others:

- Admission to the event is allowed only in a protective face mask or respirator.

- Temperature screening at the entrance.

- Availability of antiseptics in the premises, where the event will take place.

- The number of conference attendees is restricted according to the requirements of the Ministry of Healthcare.

- The distance between chairs for guests will be at least 1.5 meters.

Organizer and venue

The event is organized by the international Smile-Expo company, which specializes in industry events dedicated to innovations.

Biohacking Conference Kyiv will be held at Oasis conference hall on November 11.

More info and registration: kyiv.biohacking.events

Interfax-Ukraine - General News Partner of the event.

See the article here:
Biohacking Conference Kyiv about Efficient Health Optimization Techniques to Take Place on November 11 - Interfax-Ukraine

Read More...

Global Precision Medicine Software Market 2020 Recovering From Covid-19 Outbreak|Know More About Brand Players – The Think Curiouser

Sunday, October 25th, 2020

The research report entitled GlobalPrecision Medicine SoftwareMarket 2020 added by Syndicate Market Researchprovides professional information to evaluate the most recent Precision Medicine Software market measurements and industry situation. The report offers the research methodology and approaches followed to clear up the Precision Medicine Software industry conditions. This report studies the all-important aspects of the Precision Medicine Software market based on current market conditions and focuses on future possibilities of Precision Medicine Software market during 2020-2026.

This report research enormously examines each and every specific deciding factor of the Precision Medicine Software industry on the basis of present financial condition, Demand, Trends, Limit, Capacity, procedures encapsulated by Precision Medicine Software market competitor and their advancement framework.

Get FREE Sample Copy of Report:https://www.syndicatemarketresearch.com/sample/precision-medicine-software-market

(We Provide Free Sample copy as per your Research Requirement, also including COVID 19 impact analysis)

The research highly targets on the current industry size of the Global Precision Medicine Software market and its improvement capacity on the basis of the last 5 years data with company profile of leading players and manufacturers. The major key regions which add to the progression of Precision Medicine Software market mostly cover such as Precision Medicine Software market in North America, South America, Europe, Africa, the Middle East, and the Asian countries.

Top Players and Manufacturers Analysis in Precision Medicine Software Market:Syapse, Allscripts, Qiagen, Roper Technologies, Fabric Genomics, Foundation Medicine, Sophia Genetics, PierianDx, Human Longevity, Translational Software, Gene42 Inc, Lifeomic Health

Do Inquiry for Purchasing Report Here:https://www.syndicatemarketresearch.com/inquiry/precision-medicine-software-market

This Precision Medicine Software Market report separated into the;1. Top manufacturers2. Product Type (Cloud-based, On-premises)3. Application/ end users (Healthcare Providers, Pharmaceutical and Biotechnology Companies, Research Centers and Government Institutes, Other)4. Key Regions

Key regions covered in the world Precision Medicine Software market report include:

The five regions are in turned segment into major countries and geographies. The key countries included in the global Precision Medicine Software market report includeU.S., Canada, Germany, UK, Italy, France, Spain, China, India, Southeast Asia countries, South Korea, Japan, Australia, GCC countries, Turkey, Brazil, Egypt, Mexico, and South Africa among others.

(Our Analystcan add Regional analysis as per your Research need also)

In the first part, The Precision Medicine Software market report provides company profiling, product picture, contact information and requirements of key producers of the global market. This report comparatively delivers the past, present, and futurist Precision Medicine Software industry strategies, organization capacity, size, share, growth, and forecast analysis be featured the predicted circumstances. Moreover, the possible results and the hazard to the improvement of Precision Medicine Software market comprehensively described in this report.

In next part, the Precision Medicine Software report delivering investigation of the most essential industry players based on their organization profiles, sales volume, Precision Medicine Software market value, yearly income, gross margin, demand and supply is considered in this report, which can drive opportunity Precision Medicine Software market competitors in dynamic business parts of learning.

Browse Complete Report with [emailprotected]https://www.syndicatemarketresearch.com/market-analysis/precision-medicine-software-market.html

Key Highlights of the Precision Medicine Software Market:

Detailed research of the standard Precision Medicine Software market makers can ask the entire market to review the modernize plans and propelling examinations. Centered review of Precision Medicine Software market depends upon expansion, drive confining components and point of speculation can presume the market progress. The investigation of developing Precision Medicine Software market fragment and the dominating business sector will deal with the readers to plan the business strategies. The essential appraisal identified with Precision Medicine Software industry like the cost, sort of uses, the meaning of product, demand, and supply elements are acknowledged in this study report.

In the final part, the Global Precision Medicine Software Market report 2020 portrays business improvement designs, the Precision Medicine Software sales channel, wholesalers, buyers, merchants, studies findings, reference area, measurements sources and more.

Thanks for reading this Report; you can also get specific chapter wise, section wise or region wise reports.

Read another Report:-https://www.openpr.com/news/2160425/global-blockchain-technology-in-healthcare-covid-19

About Syndicate Market Research:

At Syndicate Market Research, we provide reports about a range of industries such as healthcare & pharma, automotive, IT, insurance, security, packaging, electronics & semiconductors, medical devices, food & beverage, software & services, manufacturing & construction, defense aerospace, agriculture, consumer goods & retailing, and so on. Every aspect of the market is covered in the report along with its regional data. Syndicate Market Research committed to the requirements of our clients, offering tailored solutions best suitable for strategy development and execution to get substantial results. Above this, we will be available for our clients 247.

Contact US:

Syndicate Market Research244 Fifth Avenue, Suite N202New York, 10001, United StatesEmail ID:[emailprotected]Website:https://www.syndicatemarketresearch.com/Blog:Syndicate Market Research Blo

Link:
Global Precision Medicine Software Market 2020 Recovering From Covid-19 Outbreak|Know More About Brand Players - The Think Curiouser

Read More...

What’s Behind All the Pro-Azerbaijan Articles? – Armenian Weekly

Sunday, October 25th, 2020

Azerbaijans President Ilham Aliyev has opened another battlefront thousands of miles away from Baku, in the pages of local and national newspapers and news sites in the US. Much like the Syrian mercenaries Baku recruited and deployed with the help of Turkish defense contractors to target Armenians, Azerbaijans US-based lobbyists are at the forefront of an information warfare that costs millions of dollars annually.

One important aspect of the work of these lobbyists is to place, disseminate and promote anti-Armenian narratives. Their tactics have evolved into a relentless smear campaign through US media outlets, painting Armenia as a close ally of Iran that undermines Western policies and Armenians as intolerant and anti-Semitic. At the same time, Azerbaijan is depicted as a beacon of tolerance, an ally of Israel and a champion of religious rights.

Bakus lobbyists continually push this narrative by placing articles in various media outlets, reaching out to editors with numerous factsheets and disseminating Baku-approved stories to contacts in positions of power. Many such propaganda pieces that are essentially commissioned by the Azerbaijani government appear in US media outlets without proper disclaimers, and therein loom the danger and deception.

Foreign Agents Registration Act (FARA) filings by Azerbaijans lobbyists show how they approach almost every major outlet from Bloomberg to CNN, the Washington Post, the Jerusalem Post, the New York Times, NBC, Al-Jazeera, San Francisco Chronicle, Sacramento Bee, Haaretz, USA Today, and Wall Street Journal; the list is almost interminably long.

Over the past few weeks, numerous articles have discussed Azerbaijans war on Armenia; many have had a bias, some suspiciously so. It may be impossible to tell which are penned by Aliyevs supporters and which are commissioned or disseminated by Bakus agents here; but a few are (and will be) known because of FARA filings.

From comments left under strikingly pro-Azerbaijani articles, it is clear that many readers have been frustrated and disheartened. Arguably, readers have a right to know whether the content they are consuming is either commissioned or part of a foreign governments information warfare. Without proper disclaimers under articles received from embassies by way of lobbyists, editors risk tarnishing the credibility of the news outlets they represent and deliver a blow to the idea of journalistic integrity. A simple one-liner would suffice, such as, This article was sent to us by [insert name of PR firm] on behalf of the Embassy of the Republic of Azerbaijan to the United States of America. Editors uncomfortable with such disclaimers might reconsider running blatant propaganda pieces that essentially import the state-sponsored narrative of a country with one of the worst media freedom records.

To give readers a clearer idea of how Azerbaijans lobbyists place and disseminate narratives that support Bakus propaganda campaign, I will take a close look at the activities of certain lobbyists employed by Aliyevs government, by examining hundreds of pages of FARA filings available in the US Department of Justice (DOJ) online archives.

An Information Warfare

In an Aug. 25 article titled Russia and Irans Dangerous Energy Gambit in the Caucasus and published by the Begin-Sadat Center for Strategic Studies, human rights lawyer and national security analyst Irina Tsukerman embraces all the talking points put out by Baku. She refers to Artsakh as a fake republic and an ersatz entity. After a series of hypotheticals (like Russia and Armenia might join forces to bring Russian biological weapons close to Azerbaijan), she proceeds to advise Baku on how to handle pro-Armenian sentiment in the west.

Azerbaijan should form a closer joint defense relationship with the US, benefiting from joint training and insights from experienced field operatives and officers. Additionally, greater resources need to be marshalled for information warfare and the political aspect of the battle being waged, including supporting professional media to counter disinformation, building personal and long-term relationships with public officials at all levels, and, most importantly, vigorously pursuing legislative and legal relief in US, European, and international bodies. Armenian officials responsible for human rights abuses should be sanctioned, she writes (italics my own).

Since a large chunk of her article deals with the Armenian National Committee of America (ANCA), which is active in DC, one might understand that Tsukerman is essentially encouraging a foreign government, Azerbaijan, to wage information warfare against a grassroots Armenian-American organization that promotes and advocates for the interests of and issues important to American citizens of Armenian origin. In other words, she is calling on Azerbaijan with its dismal media freedom record to export its relentless propaganda to the US.

In its 2020 report, Freedom House designated Azerbaijan as a consolidated authoritarian regime with a score of 10/100, observing that Constitutional guarantees for press freedom are routinely and systematically violated, as the government works to maintain a tight grip on the information landscape. Defamation remains a criminal offense. Journalists and their relatives face harassment, violence and intimidation by authorities. Many have been detained or imprisoned on fabricated charges, while others face travel bans. Armenia fared as partly free, with a score of 53/100. The report noted Independent and investigative outlets operate relatively freely in Armenia, but their work is generally found online.

We may not know what motivates Tsukermans anti-Armenian rhetoric; she has no known ties to current lobbyists for Baku.

On Oct. 20, another one of Tsukermans articles, co-authored by Jason Epstein, was published by Newsweek. Tsukerman and Epstein unite in [their] support of Sunni-majority Turkeys Shia ally, Azerbaijan, an unabashedly pro-Western country, as it is unfairly smeared. The article argues that the war is not about religion; it discusses Azerbaijans secularism, the Popes 2016 visit to Baku, religious minorities in Azerbaijan, and Ashkenazi, Georgian and Mountain Jews.

No wonder Iran, the largest Shia country in the world but with ethnic Azeris comprising of up to 30 percent of its population, feels threatened by a tolerant Azerbaijans continued geopolitical success and therefore supports Armenia, write the authors. Tsukermans co-author Epstein is the president of Southfive Strategies, LLC and a former public relations consultant for the Turkish Embassy in Washington (2002 2007); he has long considered [himself] both pro-Israel and pro-Turkey. Among Southfives past clients are the Azerbaijan Diplomatic Academy in Baku, the Turkish Embassy in Washington and the Turkish Republic of Northern Cyprus Washington office.

Epsteins work with the Azerbaijan Diplomatic Academy, which is funded by the Azerbaijani government, began on Aug. 1, 2008, when Epstein registered as a foreign agent with the DOJs FARA unit for his work with the Academy. In describing his engagement with that entity, Epstein wrote, Assisting the Academy in producing a policy conference in Azerbaijan on US-Azeri relations, as well as meetings with Azeri officials, business leaders, religious leaders, and media personalities.

When asked whether Southfive would engage in political activities and what those activities might entail, Epstein responded, Encouraging journalists to file stories on US-Azeri relations, based on their experiences at the conference and during various meetings.

The disclaimer under the Newsweek article reads: Jason Epstein is president of Southfive Strategies, LLC, an international public affairs consultancy. Irina Tsukerman is a New York-based human rights lawyer and national security/geopolitical analyst, the vice president of Timberwolf Phoenix, a media and security consultancy, and an adviser to the London-based International Justice Organization. The views expressed in this article are the writers own.

There is no mention of Epsteins past lobbying work for the governments of Azerbaijan and Turkey. A reader would have to independently research Southfive Strategies to learn that for years it had engaged in lobbying on behalf of Azerbaijan and Turkey.

Bakus US Agents

A FARA filing by the Podesta Group in 2013 details the extent of its outreach to US politicians, universities, think tanks, but also most major news outlets, including Bloomberg, Foreign Policy, CNN, Washington Post (and Times), EurasiaNet, Associated Press, USA Today, Wall Street Journal, Jerusalem Post, Al-Jazeera, Los Angeles Times, NBC, New York Times and Haaretz.

Just between June and December of 2017, Podesta received $260,735.56 for its work on behalf of the Azerbaijani Embassy in the U.S., according to a Department of Justice (DOJ) report. That year, Podesta was one of four companies registered with the DOJ for work on behalf of Azerbaijan that cost Baku $560,735.56. During a six-month period that same year, 16 companies worked on behalf of Turkey with a total (reported) price tag of $4,284,020.06. Meanwhile, during the six-month period, an Avedis Boyamian offered pro-bono policy consultation to Armenia; price tag: $0. This information is available in the DOJ report titled, Report of the Attorney General to the Congress of the United States on the Administration of the Foreign Agents Registration Act of 1938, as amended, for the six months ending December 31, 2017.

Among the lobby groups that have represented Azerbaijan in the past couple of years are the Livingston Group (contract terminated on Oct. 13), Stellar Jay Communications, BGR Government Affairs, Sanitas International, Rasky Partners (click here for an earlier and more detailed contract, and here and here for samples of their media outreach), and Baker Donelson (contracted by BGR). Meanwhile, another lobbying firm, S-3 Group, which works on behalf of the Baku-based Investment Corporation owned by Seyidov Tural Oglu, has create[d] and place[d] earned and digital media to further diplomacy between America and Azerbaijan, according to a DOJ filing; for instance, S-3 sent out pro-Azerbaijan factsheets on Oct. 15.

To get an idea of the ties, experience and expertise some of these lobby groups retain, a quick glance at the rank and file of BGR Public Affairs will suffice. Among their team members are: former Governor of Mississippi Haley Barbour; former Policy Director at the Senate Finance Committee Matt Hoffmann; Former Representative Sean Duffy (R-WI); former Senior Executive Clandestine Service Officer with the Central Intelligence Agency (CIA) Daniel Hoffman; former FBI man Tom Locke; former US Ambassador to NATO Kurt Volker; former Director of Legislative Affairs for the National Security Council Mark Tavlarides; former senior USAID official Lester Munson; a Frank Ahrens who can arrange client interviews with Fox News, CNN, The Washington Post and major wire services; and a Jeff Birnbaum who is a former White House, congressional and tax reporter for the Wall Street Journal, a senior political correspondent for Time Magazine, Washington bureau chief for Fortune Magazine and a columnist for the Washington Post.

When Azerbaijan and Turkey pay millions to employ such lobbying firms, they are in effect buying ease of access to major national news services.

A Stellar Case

The case of one public relations firm employed by Baku might offer a glimpse into the Azeri lobbying efforts through pro-Azerbaijan articles in US media. The articles pushed on various editors deal with that general theme of tolerant Azerbaijan and intolerant Armenia. Whatever information warfare Tsukerman might have been alluding to in her article is displayed below.

At the center of the story is Jacob Kamaras, the former editor-in-chief of the Jewish National Syndicate (JNS), where pro-Azerbaijan and anti-Armenian articles have appeared in the past two years (for instance, Irina Tsukermans Oct. 12 article), including pieces that promote denial of the Armenian Genocide. Kamaras is the founder and chief of Stellar Jay Communications, which actively lobbied for the Azerbaijani Embassy in the US in 2020, and about which Julian Pecquet, founder and editor of the Foreign Lobby Report, has written. Note that Kamaras has filed a Fictitious Business Name Statement for his company with the DOJ.

Kamaras registered to lobby for the Azerbaijani Embassy on Jan. 31, 2020. The DOJ form informs that the registrant engages with Azerbaijans Ambassador Elin Suleymanov and receives a $3,300 fee per project. Kamaras principal mode of operation is through outreach to newspapers and editors, as noted in another DOJ file. Still another DOJ filing reveals that Kamaras, whose work for the Embassy entailed media consulting and op-ed placement, was paid $56,100 between Feb. 17 and July 10, 2020, presumably for 17 projects.

Among the papers Kamaras submitted to the DOJ are a number of emails he sent to news outlets, urging them to publish certain pro-Azerbaijan articles and offering certain pro-Azerbaijan talking points. There are 14 files (excluding the companys registration) that span the first eight months of the year; the last disclosure is dated August 7.

Propaganda: Israel Should Ally with Tolerant Azerbaijan

In the first email dated Feb. 12, addressed to the editors at the conservative CNSNews.com, Kamaras asks the news website to consider publishing an article by Maayan Hoffman, the news editor at The Jerusalem Post, titled, A Jewish-Muslim paradigm for peace. Hoffman argues that Azerbaijan has pioneered a paradigm for warm Muslim ties with Israel, the nation Tehran repeatedly vows to wipe off the map Israel only stands to benefit from having an ally like Azerbaijan on the border of arguably the Jewish states fiercest enemy. She stresses that Jews live in Azerbaijan in peace and prosperity and details various developments in the benevolent attitude of Baku towards its Jewish minority population.

Kamaras email (like all his other emails discussed below) ends with a disclaimer noting that the email and its contents are sent by Stellar Jay Communications on behalf of the Azerbaijani Embassy.

On Feb. 13, CNSNews published the story, slightly altering the headline to read, Heres What a Jewish-Muslim Paradigm for Peace Looks Like. A brief bio of the author appeared below the article: Maayan Hoffman is news editor and head of online content and strategy at The Jerusalem Post. She has been an American-Israeli international journalist for more than two decades. There was no mention of Stellar Jay Communications or the Azerbaijani Embassy.

Propaganda: Armenia is Anti-Semitic

Kamaras second email dated March 9 is addressed to Rob Shimshock of CNSNews, containing yet another article, this time by Jesse Bogner and titled The old anti-Semitism is alive and well. This piece alleges that there is medieval-style anti-Semitism coming from Armenian organizations and commentators, and that [T]he ANCAs recent rhetoric on Twitter represents the latest indicator of not only the anti-Semitism emanating from Armenia, one of the worlds oldest Christian nations, but also of the disturbing perpetuation of classical Christian anti-Semitism. Of course, Bogner portrays Azerbaijan as a haven of tolerance. By contrast, Armenias Muslim-majority neighbor has a deep relationship with Israel, no history of anti-Semitism, and a prosperous Jewish community of its own for more than two millennia, he writes.

Apparently CNSNews did not publish Bogners article. On March 15, the piece was published on Bogners blog on The Times of Israel. Again, there was no mention of the Azerbaijani Embassy; just Bogners bio: Jesse Bogner is an author and journalist. His memoir and social critique, The Egotist, has been translated into five languages. His work has been featured in The Daily Caller, MSN, The Daily Wire and The Huffington Post. His book of articles, Tikkunim (Corrections), was released in January 2018.

It is outside the scope of this article to counter such propaganda. However, I will refer you to Yoav Loeffs Jan. 27 article titled, Armenias Antisemitism? The Truth Is Different, in The Jerusalem Post, which he wrote coincidentally in response to a piece by Hoffmanthe same Hoffman whose articles Kamaras disseminated on behalf of Azerbaijans Embassy. Loeff, who teaches Armenian history and culture at the Hebrew University of Jerusalem, is Jewish and has traveled to Armenia with other Jews and Israelis on many occasions, and stresses that he has never heard a hint of antisemitic expression.

If there is some criticism, it is usually about Israels hesitation to recognize the Armenian genocide that was perpetrated by the Ottoman Empire he writes.

Armenias small Jewish community never suffered antisemitism in their adopted homeland. Most of them left in the early 1990s, after the severe earthquake in the north of the country in 1988 and the collapse of the Soviet Union, explains Loeff. He notes the dire economic situation following the earthquake and the Artsakh war and adds, They did not leave because they faced any antisemitism; they left because they sought better life.

Loeff also discusses the various ways in which Armenian government representatives had honored Holocaust victims, from Armenian President Armen Sarkissians attendance at the World Holocaust Forum in Jerusalem to the erection of a monument in Yerevan in memory of the victims of the Holocaust and the Armenian Genocide. Unfortunately, there is no parallel such monument in Israel, he adds.

Propaganda: Azerbaijan is a Friend to Israel

On March 13, Kamaras emailed The Jewish Voice editor Fern Sidman, offering him a piece by Hoffman, this time titled, Could fighting coronavirus be the latest frontier in the Israel-Azerbaijan relationship? Hoffman noted the presence of Azerbaijans Finance Minister Samir Shafirov at the AIPAC Policy Conference and quoted him to have said, Cooperation with Israel is not limited to oil supply; we are interested in widening cooperation in defense and the transfer of technology. Apparently Shafirov also read Azerbaijans first-lady-turned-vice-president Mehriban Aliyevas remarks praising Azerbaijani-Jewish ties in the US. The gist of the article was the importance of strengthening Azerbaijani-Israeli ties. The email closed with the usual disclaimer about Kamaras communicating on behalf of the Azerbaijani Embassy.

Hoffmans piece was accepted and published without any mention of Kamaras firm or the Azerbaijani Embassy. However, some days later, NBC news published a piece highlighting Hoffmans article as an example of foreign governments using American lobbyists to promote their efforts to fight the coronavirus outbreak and safeguard their countries reputations in the U.S. capital. NBC goes on to point out that The piece was written by Maayan Hoffman, identified as a Jerusalem Post news editor, but the published version makes no mention that the commentary was placed by Stellar Jay Communications, a lobbying firm representing the government of Azerbaijan, as a FARA filing shows.

NBC was right about foreign governments promoting their countries, safeguarding their reputations and placing op-eds in various papers. What NBC failed to understand is that this was not about the coronavirus, but part of an information war that ultimately feeds and bolsters the myth of the religiously tolerant Azerbaijan and the intolerant Armenia; and that is one of the key objectives of Baku, and by extension their US agents.

Propaganda: Armenia is a Friend to Iran

On April 23, Kamaras sent out another email to CNSNews with an article written by Bogner, whoin Kamaras wordsexamines how the coronavirus is not stopping Iran from fueling conflict and undermining sanctions through its proxies. Specifically, he looks at Armenias role in empowering Iran economically. The article, titled, Coronavirus doesnt stop Iran from fueling the fire of conflict, accuses Iranian trucks of delivering fuel to Nagorno-Karabakh, the Armenian-occupied region which several U.N. resolutions affirm as part of Azerbaijan, charges Armenian banks of enabling Tehran, and faults Democratic US lawmakers for having a pro-Armenian policy agenda.

The article ignores Azerbaijans ties with Iran, the fact that in 2019 Azerbaijans imports from Iran were worth US $452.63 million and exports at US $41.13 million, while Armenias imports from Iran were worth US $324.7 million and exports at US $83.84 million, according to the United Nations COMTRADE database. In other words, both countries maintain an economic relationship with their sanctioned neighbor.

Once again, Bogners piece did not appear in CNSNews and instead was published on his blog on the Times of Israel without any mention of the Azerbaijani Embassy or Jay Stellar Communications.

Propaganda: Azerbaijan Champions Religious Freedom

Kamaras next email (May 6) was also to CNSNews, in which it becomes clear that Rob Shimshock (the recipient) did not respond to the lobbyists previous two emails (which also explains why Bogners pieces ended up on his blog). This time, Kamaras submits his own article titled Azerbaijans postponed Formula 1 race transcends sports about which he tells Shimshock, I write that despite the events postponement this year, the annual Formula 1 auto race hosted by Muslim-majority Azerbaijan particularly during the Islamic holy month of Ramadan is a powerful display of religious freedom, especially in a world plagued by sectarian conflict and now by the invisible enemy of the coronavirus.

What Kamaras fails to mention is that Freedom House gave Azerbaijan a score of 0 out 4 for religious freedom in its 2020 report, which noted, The regime exercises control over religion through state-affiliated entities such as the Caucasus Muslim Board. Religious communities that attempt to operate independently face burdensome registration requirements, interference with the importation and distribution of printed religious materials, and arrest and harassment of religious leaders with international ties or a significant following. In other words, the idea of a religiously tolerant Azerbaijan is a myth nurtured by Bakus agents abroad.

In any case, at the end of the article submission, Kamaras includes his bio: Jacob Kamaras, former editor in chief of the Jewish News Syndicate, is noted for his work on the Middle East and American politics. His writing has appeared in the Washington Times, Independent Journal Review, the American Spectator, and various Jewish and Israeli media. It makes no mention of his role as a lobbyist on behalf of the Embassy of Azerbaijan to the US. However, the email does end with the usual disclaimer.

CNSNews published the article on May 7, slightly altering the title to read, Azerbaijans Grand Prix Transcends Sports, Speaks to Religious Freedom. However, it added the following to Kamaras bio: Jacob Kamaras is founder of Stellar Jay Communications, a PR firm representing Azerbaijan. The next day, another lobbyist on behalf of Azerbaijan, Mark Tavlarides of the BGR Group, emailed the article out to relevant contacts, urging them to read it.

Propaganda: Israel and Azerbaijan are Partners (and Trailblazers in the Understanding of Aging)

A few days later, Kamaras reached out to the editor of the Salinas Californian, Silas Lyons, with a story written by Diana Cohen Altman, former executive director of the Karabakh Foundation and a contributor to the JNS. Altmans piece was about Azerbaijanis who live up to 120 years old in Lankaran. Altman discusses diet, genetics and clusters of very old people in Azerbaijan, as well as longevity in Ashkenazi Jewish populations. Quoted in the piece is a surgeon who is a member of the Azerbaijan-Israel Inter-Parliamentary Work Group. The piece concludes with yet another nod to Azerbaijani-Israeli friendship with these words: Azerbaijan has fostered significant partnerships in the humanities and other disciplines, and the West is building an understanding of Azerbaijani culture and contributions. Amid the pandemic and in the coming years, the U.S. scientific community may look to Israel and Azerbaijan who are partners in technical and other arenas for breakthroughs in the understanding of aging.

The piece did not appear in The Californian. Instead, it was published by The Jerusalem Post on June 4. The final paragraphs were altered a bit, and there was this addition: The Azerbaijani superaging phenomenon may also be of particular interest to social scientists, given major societal changes during the past century. Consider this: Someone over the age of 100 might have witnessed what is now the Republic of Azerbaijan as a portion of the Russian Empire, a part of the early Azerbaijani Democratic Republic, and as an S.S.R. of the Soviet Union. In effect, this addition attempts to insert a historical footnote in this article that on the surface appears to be about longevity.

Altmans bio appears at the end of the piece: Diana Cohen Altman, principal of Cultural Diplomacy Associates, L.L.C., and former executive director of the US cultural non-profit Karabakh Foundation, writes extensively about Azerbaijani cultural and civil-society topics. It made no mention of the Embassy of Azerbaijan or Jay Stellar Communications. Also to note, Altman is still listed on the Karabakh Foundations website as its Executive Director.

Propaganda: Armenians are Intolerant, Anti-Semitic

On June 11, through Kamaras, Baku resorted again to charges of anti-Semitism as a desperate attempt to vilify Armenian Americans. An email informs that Kamaras own article appeared in BreakingIsraelNews (Israel365News.com), titled Armenias Self-Defeating Campaign Against Christians. The article ran as an op-ed. It decried Armenian-American opposition to evangelical pastor Rev. Johnnie Moores support of Azerbaijan and Trumps Middle East policies, singled out Asbarez news for its coverage and bashed the ANCA, accusing it of anti-Semitic tweets.

Although at the base of his email, Kamaras included his disclaimerThis material is distributed by Stellar Jay Communications on behalf of the Embassy of the Republic of Azerbaijan to the United States of Americathe published article made no mention of the authors bio or of his work on behalf of the Azerbaijani Embassy. Readers were (and continue to be) misled into believing the piece was written by a concerned writer and not a paid agent of Azerbaijans propaganda campaign. The Azerbaijani news.az reprinted the article, also without any mention of Kamaras role as a foreign agent for Baku.

Propaganda: Armenia is an Occupier; Unreliable Partner; Aids Iran

On July 14, Kamaras approached The Washington Free Beacon with a list of Azerbaijani talking points on the escalation of violence between Armenia and Azerbaijan. I wanted to share a few angles below that could help you provide broader context in any story, if you choose to pursue one. Should you want to set up a phone interview with the ambassador, please let me know and Ill be happy to arrange it, wrote Kamaras. The Beacon did not take him up on the offer. In fact their last report that even mentions Azerbaijan ran in January of this year. Nonetheless, its worth reviewing Kamaras talking points.

Aside from highlighting some European support for Azerbaijans territorial integrity, Kamaras shared an article by none other than Bogner in American Thinker titled, Democrats West Bank rhetoric rings hollow, in which the author asks, Where is the condemnation of Armenias occupation of the same percentage of internationally recognized Azerbaijani territory, in the Nagorno-Karabakh region?; another article by Paul Miller in the JNS titled, Beware of the sanctions busters, accuses Armenia of offering the [Iranian] mullahs one of their best escape routes from crippling American sanctions; as well as Hoffmans article in BreakingIsraelNews titled, A Nation that is Faithful to Iran Is no Reliable Partner (one can glean the spirit of the article from the title). He also shared a July 7 article in Arab News by Iranian American journalist Adelle Nazarian, a foreign policy analyst with Breitbart News who was in Azerbaijan in 2019. In it, Nazarian argues that Now is the time for US lawmakers to echo Europes support for territorial integrity. Hypocrisy should no longer be accepted.

Propaganda: Armenians are Plagued by Extremist Ideologies(Like Nazism and Anti-Semitism)

On July 13, Kamaras emailed Fox News correspondent Hollie McKay, offering her the opportunity to interview Azerbaijans Ambassador to the US Elin Suleymanov. McKay had interviewed the Ambassador in March 2019. She did not interview the Ambassador in July, but Fox News did speak with him on Sept. 28, just as Azerbaijan launched its offensive. (On Oct. 4 McKay did report on the recruitment of Syrian fighters by Turkish defense contractors to fight in Azerbaijan).

In early August, Kamaras approached a number of news sites on behalf of Amb. Suleymanov. On Aug. 5, he emailed Mercury News asking them to publish an article penned by the Ambassador, titled Hate crimes have no place under the California sun.

The Ambassadors article centers on a scuffle between Armenian and Azerbaijani protesters in Los Angeles. He proceeds to highlight some statements from Jewish American groups regarding the incident and suddenly hurls allegations of anti-Semitism. Both Armenia and the Armenian communities abroad have long been plagued by extremist ideologies, political violence and a complicated history with anti-Semitism, Nazi collaborators and Middle Eastern radicals, he writes.

Such broad charges are not only insulting to Armenians worldwide and Armenian Americans, many of whom fought the Nazis, but also warps history, erasing the sacrifices of many like the members of the Manouchian Group, one of the most active French resistance groups. Of course, this is coming from the representative of a government that wholeheartedly joins neighbor Turkey in its unashamed and continued denial of the genocide perpetrated by its Ottoman Turkish predecessor.

Essentially, the Ambassador is relying on charges of anti-Semitism against Armenians to draw support for the Azerbaijani policies and claims against Artsakh. By doing so, he is using the very real presence and danger of anti-Semitism in the world as a tool to further Bakus agenda and in the hopes of garnering Jewish American and Israeli sympathies. As Kamaras previous emails show, Bakus tactics have at their core the manipulation of fears towards both Iran and anti-Semitism.

The Ambassadors article was presumably rejected by Mercury News, because on Aug. 6 Kamaras submitted the same piece to the San Francisco Chronicle. Three minutes later, he sent the piece to The Sacramento Bee; and a minute later to The Hill. The article was finally published in The Monterey County Herald on Aug. 12, despite its overt propagandizing and vilification of Armenians worldwide.

That is the last of Kamaras activities submitted to the DOJ.

A Glance at BGR

Other lobby groups, such as BGR, also heavily publicized pro-Azerbaijan viewpoints and articles, and reached out to various media outlets for interviews, or to offer talking points. For instance, the DOJ FARA registration unit received a copy of an email from Mark Tavlarides of the BGR Group, which shared an article by the same Nazarian, titled, Azerbaijan: A Nation that Bears the Torch, and Burden, of Bringing Religious Freedom to its Less Tolerant Neighbours in the Region.

The author, Adelle Nazarian, visited Azerbaijans 5th World Forum on Intercultural Dialogue in Baku. Nazarian noted the insightful meetings and visits which left her acutely aware of the sensitive nature of Azerbaijans position as a potential kingmaker for the cause of religious freedom and unity between the three Abrahamic faiths in the region. She expressed hope that religious freedom would also flourish in Azerbaijans neighbors in the region, wrote Tavlarides in his email.

Tavlarides has on many occasions disseminated pro-Azerbaijan articles on behalf of the Embassy, such as a piece by Hoffman in the JNS, titled Azerbaijani national hero provides a paradigm for Jewish-Muslim relations. On numerous other instances, Tavlarides sent out the links to articles, official Azerbaijani statements, resources, factsheets (including an Oct. 5 email), press releases, the pro-Azerbaijan statements of various organizations and politicians, and tweets such as one sent out by Israels Ambassador to the US touting Azerbaijan as a beacon of religious tolerance, as well as another one by Luke Coffey, director of Foreign Policy Studies at The Heritage Foundation, critical of Armenia and Armenians.

In a turn from the cynical to the absurd, Tavlarides also disseminated a link to an episode of the CBS show Seal Team, which depicts the fictional support of elite US forces to help protect an Azerbaijani power plant from a potential attack by Armenian loyalists, Shiite militia, or foreign powers looking to reduce American influence in the region. Tavlarides went on to stress that The scene emphasizes the strategic role of Azerbaijan as our only ally in the Caspian Sea and a deterrent to unaligned powers in the area.

Azerbaijan paid BGR $510,000 in 2019, $600,000 in 2018, and $490,000 in 2017.

The Case of Brenda Shaffer

In 2015, Till Bruckner of the Organized Crime and Corruption Reporting Project (OCCRP) published a piece titled, How to Build Yourself a Stealth Lobbyist, Azerbaijani Style. The focus of the article is Brenda Shaffer, a visiting researcher and adjunct professor at Georgetown University, a Senior Fellow at the Atlantic Councils Global Energy Center, professor at the University of Haifa, and former head of the Caspian Studies Program at Harvard, which was funded by the Azerbaijan Chamber of Commerce. Bruckner discusses Shaffers various activities and lays out her myriad connections with Azerbaijans lobbyists, including her role as adviser to the State Oil Company of the Azerbaijan Republic (SOCAR).

According to Bruckner, Shaffers activities included testifying before the House of Representatives Committee on International Relations, contributing to various DC think tanks (including a panel discussion on Azerbaijan, hosted by the Carnegie Endowment for International Peace, during which she reportedly praised the countrys vibrant press), and writing numerous op-eds for US and Israeli news outlets. She was often consulted on matters relating to Azerbaijanwhether by the media or US officials.

Supported by an overseas regime and an assorted network of overt and undercover lobbyists, she used oil money to build her academic credentials, then in turn used those credentials to promote Azerbaijans agendas through Congressional testimony, dozens of newspaper op-eds and media appearances, countless think tank events, and even scholarly publications, wrote Bruckner.

In a 2006 Harpers Magazine piece titled Academics for Hire, journalist Ken Silverstein wrote, Caspian watchers beware: the next time you see or hear an independent American expert talking about how the regions rulers are implementing bold reforms, check the experts credentials to see just how independent he or she truly is.

After inquiries by Bruckner, some newspapers like The New York Times and The Washington Post added disclaimers under Shaffers articles, disclosing her roles and ties to SOCAR. Others did not.

Shaffer continues to publish op-eds on the subject. For instance, on Oct. 14, JNS ran a piece by Sean Savage titled, How the Armenian-Azerbaijani conflict could impact Israels regional strategic landscape.

Israel and Azerbaijan maintain a strategic alliance. It is not just about arms sales or oil, but a very deep strategic cooperation, she told JNS, adding, Israel has friendly ties with the Armenian people and is home to a vibrant Armenian community. On strategic issues, however, the two states are on different sides. Armenia has close cooperation with Iran, and much of the military supplies to Armenia today transit Iranian territory.

Shaffers credentials were left as a senior fellow at the Atlantic Councils Global Energy Center. The JNS piece was reprinted in multiple outlets.

Armenian Americans Fight Back

The ANCA, the Armenian Assembly and many concerned Armenian Americans have been vocal with their efforts to pressure lobbyists to back down and terminate their contracts, as Foreign Lobbys Pecquet reports. Already over the weekend, the Armenian diaspora bombarded the S-3 Group with more than a thousand emails with an identical message pressuring the Washington public affairs firm to stop representing a new client from Azerbaijan (Foreign Lobby Report was copied on the emails), wrote Pecquet, adding, The firm recently picked up a Baku-based company called Investment Corporation, LLC for $25,000 per month to create and place earned and digital media to further diplomacy. The diaspora letter, which you can read in its entirety here, describes S-3s client as a thinly veiled front for the Government of Azerbaijan through a proxy shell corporation.

Their aim is to vilify Armenians worldwide.

The Livingston Group terminated its contract with the government of Azerbaijan on Oct. 13. Pecquet notes that this came three months after the lobby group informed the DOJ that it was negotiating another contract with Baku. Pecquet also reported that DLA Piper, a lobby group working for the state-owned Azerbaijan Railways CJSC, terminated its contract on Oct. 19. DLA Piper was contracted to provide the foreign principal with legal advice and assistance relating to U.S. sanctions on Iran that affect the transport of oil, gas, and other petrochemical products that originate in third countries and that transit through Iran.

Meanwhile, the lobbying firm Mercury Public Affairs cut its ties with Turkey on Oct. 23, after pressure from the Armenian American community. The decision came following protests led by the ANCA and the Armenian Assembly outside the firms offices, as well as pressure from current clients like Los Angeles County, California State Assembly, and Los Angeles Community College District representatives, reported Politico.

A lot of people have bought a lot of summer homes and fishing boats and put their grandkids through college by lying about Armenia and covering up for Azerbaijan, ANCA Executive Director Aram Hamparian told Politico.

Hamparian said that BGR was next on the list.

Fact: Baku Aims to Vilify Armenians through US Media

Some of the articles disseminated by these lobby groups employed by Azerbaijan cross-link with others written by authors like Bogner, desperately trying to paint Armenia as a threat like Iran, and Armenians as anti-Semites. Reading these articles, one might not even realize that there is a Jewish community in Armenia as well, and they too have spoken up (See Lara Setrakians article in Haaretz titled, Im Jewish and Armenian. Israeli Weapons Are Killing My People). Their existence is not weaponized in western media by either Armenians or the Armenian government.

In all this, it is clear that Azerbaijans smear campaign against Armenia relies on those two tales: Armenia is dangerous; and Armenians are intolerant and anti-Semitic. The basic calculations run something like this: Israel is good; Iran is bad; Armenia is to Azerbaijan what Iran is to Israel; therefore, Armenia must be bad, and Azerbaijan must be good; and furthermore, Israel and Azerbaijan must stand united, while Iran and Armenia are the enemy and must be sanctioned. These are the points that are being pushed by Bakus lobbyists to elicit an unfavorable public perception of Armenia and Armenians. Their aim is to vilify Armenians worldwide. The sheer number of articles pushing this narrative is astounding. Some of them are paid for and disseminated by Azerbaijans lobbyists, and published without any disclaimers to highlight that fact. The propaganda is so blatant that one wonders how anyonewhether readers or editorscould take any of these pieces seriously.

However, the responsibility to vet and flag such articles falls squarely at the feet of editors. By publishing articles without the appropriate scrutiny and disclaimers, editors are complicit in the disinformation campaign and agents of Bakus information war. Mercenaries and lobbyists are motivated by Aliyevs petro-dollars. One can only hope that editors are driven by the pursuit of truth; and those who are not should consider sending their resumes to the Azerbaijani Embassy in DC.

Authors note: Id like to thank Khatchig Mouradian for his feedback. This article does not deal with the activities of lobby groups working on behalf of Turkey, or the financial contributions of Azerbaijans lobby groups to US politicians running for office, or other activities and outreach efforts (such as the Oct. 2 Zoom session with Amb. Suleymanov and congressional staff hosted by BGR), as they are outside the scope of this piece. Those interested can read more about Azerbaijans lobbying efforts at Opensecrets.org, a website that tracks developments in the shady lobbying world.

Nanore Barsoumian was the editor of the Armenian Weekly from 2014 to 2016. She served as assistant editor of the Armenian Weekly from 2010 to 2014. Her writings focus on human rights, politics, poverty, and environmental and gender issues. She has reported from Armenia, Nagorno-Karabagh, Javakhk and Turkey. She earned her B.A. degree in Political Science and English and her M.A. in Conflict Resolution from the University of Massachusetts (Boston).

Continued here:
What's Behind All the Pro-Azerbaijan Articles? - Armenian Weekly

Read More...

Global Precision Medicine Software Market (COVID-19 Analysis) Industry Share, Growth, Trends Analysis Report 2020-26 – The Think Curiouser

Sunday, October 25th, 2020

In the latest Research Report onGlobalPrecision Medicine Software Market offers an Exclusive Research analysis of the present scenario of the global market.This report contains market revenue, sales, Precision Medicine Software production and manufacturing cost that could help you to get a better view on the market. The Report Focuses on the key global Precision Medicine Software industry manufacturers to describe and analyze the sales volume, value, market share, market competition landscape withSWOTanalysis and development plans in next few years.Major parameters covered under these company profiles include revenues, gross profits, operating income,COGS, EBITDA, sales volume, product offerings, company landscape analysis, key strategic moves, key recent developments, and technological roadmap.Syndicatemarketresearch providesa complete understanding of general market scenarios and future market situations to prepare for rising above the challenges and ensuring strong growth,the complete analysis of Precision Medicine Software Market Size, Data and development forecast from 2020-2026.

Download FREE Sample Report here:-https://www.syndicatemarketresearch.com/sample/precision-medicine-software-market

(We Provide Free Sample copy as per your Research Requirement, also including COVID 19 impact analysis)

The Major Manufactures covered in this Report:-Syapse, Allscripts, Qiagen, Roper Technologies, Fabric Genomics, Foundation Medicine, Sophia Genetics, PierianDx, Human Longevity, Translational Software, Gene42 Inc, Lifeomic Health

Global Precision Medicine Software Market Product and Application Are:-

Product:Cloud-based, On-premises

Application:Healthcare Providers, Pharmaceutical and Biotechnology Companies, Research Centers and Government Institutes, Other

Syndicatemarketresearch analysts covers all key parameters required for COVID-19 effect on business industry, economic implications their trends, factors, consumer behavior on shopping, effect on spending lot of money on advertising and also on useful industries like medical, transportation, food and Beverage.The globally rising of Bio crisis COVID-19 has many businesses are struggling and confused on what steps to take to minimize or maximize the economic impact.

The Global Precision Medicine Software Market Research Report Forecast2020-2026is a valuable source of insightful data for business strategists. It provides the Precision Medicine Software industry overview with growth analysis, historical & futuristic cost, revenue, demand and supply data. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Precision Medicine Software market study provides comprehensive data which enhances the understanding scope and application of this report.

Geographically, Global Precision Medicine Software Market covers:-United States, Europe, China, Japan, India and Southeast Asia and rest of the world

(Our Analystcan add Regional analysis as per your Research need also)

Timeline for Analysis:-

Key Stakeholders

To Get Depth Knowledge about Precision Medicine Software Market Report, Enquiry here:-https://www.syndicatemarketresearch.com/inquiry/precision-medicine-software-market

Key questions answered in this report

The study objectives of this report are:-

Syndicate Market Research provides customization of reports as per your need. The report can be altered to meet your requirements. Contact our sales team, who will guarantee you to get a report that suits your needs.

If you have any special requirements, please let us know and we will offer you the report as you want.

View Customized Full [emailprotected]https://www.syndicatemarketresearch.com/market-analysis/precision-medicine-software-market.html

Read other Report:-https://www.openpr.com/news/2160425/global-blockchain-technology-in-healthcare-covid-19

Contact US:

Syndicate Market Research244 Fifth Avenue, Suite N202New York, 10001, United StatesEmail ID:[emailprotected]Website:https://www.syndicatemarketresearch.com/Blog:Syndicate Market Research Blog

See the article here:
Global Precision Medicine Software Market (COVID-19 Analysis) Industry Share, Growth, Trends Analysis Report 2020-26 - The Think Curiouser

Read More...

AI Medicine Software Industry Market Outlook | Development Factors, Latest Opportunities and Forecast 2025 – The Think Curiouser

Sunday, October 25th, 2020

Market Study Report, LLC, provides a research on the AI Medicine Software Industry market which offers a concise summary pertaining to industry valuation, SWOT Analysis, market size, revenue estimation and geographical outlook of the business vertical. The study descriptively draws out the competitive backdrop of eminent players driving the AI Medicine Software Industry market, including their product offerings and growth plans.

The latest research report on the AI Medicine Software Industry market assesses the major factors influencing industry growth with respect to the competitive dynamics and geographical reach. It also ensembles the challenges prevalent in this industry vertical and identifies opportunities that will further aid business expansion. Further, the report revisits all areas of the business to cover the impact of COVID-19 pandemic so as to assist stakeholders in devising new strategies and reinforcing their position in the market.

Request a sample Report of AI Medicine Software Industry Market at:https://www.marketstudyreport.com/request-a-sample/2767819?utm_source=thinkcuriouser.com&utm_medium=SK

Key pointers from COVID-19 impact analysis:

Important inclusions in the AI Medicine Software Industry market report:

Ask for Discount on AI Medicine Software Industry Market Report at:https://www.marketstudyreport.com/check-for-discount/2767819?utm_source=thinkcuriouser.com&utm_medium=SK

Regional scope:

TOC of AI Medicine Software Industry Market Report Includes:

The Report Answers the key Questions

For More Details On this Report: https://www.marketstudyreport.com/reports/covid-19-outbreak-global-ai-medicine-software-industry-market-report-development-trends-threats-opportunities-and-competitive-landscape-in-2020

Related Reports:

1. Global Wearable Payment Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)Read More: https://www.marketstudyreport.com/reports/global-wearable-payment-market-report-2020-by-key-players-types-applications-countries-market-size-forecast-to-2026-based-on-2020-covid-19-worldwide-spread

2. Global Home Design Software Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)Read More: https://www.marketstudyreport.com/reports/global-home-design-software-market-report-2020-by-key-players-types-applications-countries-market-size-forecast-to-2026-based-on-2020-covid-19-worldwide-spread

Related Report : https://www.marketwatch.com/press-release/global-multi-screen-content-discovery-engines-market-to-show-strong-growth-at-cagr-of-271-by-2025-2020-10-22

Contact Us:Corporate Sales,Market Study Report LLCPhone: 1-302-273-0910Toll Free: 1-866-764-2150 Email: [emailprotected]

Read more from the original source:
AI Medicine Software Industry Market Outlook | Development Factors, Latest Opportunities and Forecast 2025 - The Think Curiouser

Read More...

Flint children exposed to lead suffer from dental problems, learning disabilities, other issues – MLive.com

Sunday, October 25th, 2020

FLINT, MI Dachelle McDonalds 10-year-old daughter has had numerous dental visits, a dental operation and teeth that seemed to practically fall out of her mouth without any effort.

McDonald isnt entirely sure any of those issues are related to lead exposure, but her daughter, Neveah Dixon, was drinking the lead-poisoned water just like many others six years ago when Flint changed its water source from treated Detroit Water and Sewerage Department water to the Flint River.

She could just pull her teeth out of her mouth when they started getting loose, McDonald said. It was just weird the way her teeth fell out her mouth.

McDonald remembers her daughter as having issues with her teeth for as long as shes had them.

Her teeth - she always has teeth problems, were always at the dentist, McDonald said. Her skin has two-tone on her face, which is weird because no one in my family, no one has skin like that.

In Flint during the water crisis, the percentage of children with elevated blood lead levels nearly doubled citywide, and nearly tripled among children in high risk areas of lead exposure, according to research by Dr. Mona Hanna-Attisha, the pediatrician credited with exposing the health crisis.

Lead exposure can affect children in different ways, Hanna-Attisha said.

One of the biggest concerns with the water crisis in regard to teeth is the lack of fluoride from not drinking public water, Hanna-Attisha said. Tap water has added fluoride to prevent dental cavities. When people stopped drinking tap water and transitioned to bottled water, they lost fluoride.

Some bottled water has fluoride, but many does not, Hanna-Attisha added.

In late August, state officials announced children 6 years old and younger during the Flint water crisis were the biggest potential beneficiaries of a historic $600 million settlement with the state of Michigan.

How does lead affect children?

According to the Centers for Disease Control and Prevention, exposure to lead can seriously harm a childs health. The adverse effects can include damage to the brain and nervous system, slowed growth and development, learning and behavior problems, and hearing and speech problems.

The health effects can include lower IQ, decreased ability to pay attention, and underperformance in school.

Hanna-Attisha said based on the science of lead, there is no safe level of lead that children can be exposed to.

Its probably the oldest and most well-studied of poisons, Hanna-Attisha said. Weve known about the evil of lead literally for centuries, weve known that lead was bad. Levels that we thought were OK decades ago when we had a lot of lead in paint and gasoline and plumbing - we now know through amazing science and research that theyre no longer OK.

Hanna-Attisha works with Neurodevelopmental Center of Excellence, located inside the Genesee Health System at 420 W. Fifth Ave., to offer assessments to children and individuals impacted by the Flint water crisis.

The big crux of our work, especially with the neurodevelopmental center is to see how kids are doing now and to get them what they need, now, Hanna-Attisha said.

To receive a free and Medicaid covered neuropsychological assessment, the individual must meet several requirements. Visit here to see the list.

Lead in paint, gasoline and plumbing were all banned, starting with gasoline in 1970, leaded-paint in 1978, and lead in plumbing in 1986. However, at the time lead free was defined as solder and flux with no more than 0.2 percent lead and pipes with no more than 8 percent, according to the U.S. Environmental Protection Agency.

Lead is quickly absorbed into the bloodstream. The half-life (time it takes for the amount to decline by 50 percent) of lead in blood is 30 days; some of the absorbed lead is excreted in urine, sweat, and feces. However, some of the absorbed lead is stored in other body tissues, mostly in bone. A persons body burden of lead is the total amount of lead that has accumulated from exposure over time and is stored in the body, said Perri Zeitz Ruckart, health scientist, for Lead Poisoning Prevention and Surveillance Branch, National Center for Environmental Health and Centers for Disease Control and Prevention.

Hanna-Attisha said when issues do present after being exposed to lead, its hard to prove causation.

Its really hard because theres a long time lag of the time from when youve been exposed to when you have a problem. In addition, the problem that you have - say its a learning disability - it can be caused by lots of other stuff too, right?

Hanna-Attisha pointed out issues that stem from lead exposure are multifactorial. Conditions such as poverty, poor nutrition and poor schools can all contribute to learning disability or issue.

Its so important that we have sequential assessments of people so that we can continue to follow folks over time, said Hanna-Attisha. So we can see the potential consequences.

Lead in families

Dixon is a bright, 5-foot-9, intuitive fifth grader at Eagles Nest Academy. Her teachers describe her as a leader in class.

She was 4 years old when the water was switched.

All her blood levels are perfect, shes fine as far as thats concerned. Her teeth - the dentist said it could possibly be that (exposure to lead) but all her blood work says shes fine, so nobody said shes lead poisoned. So, its like how do you determine that? McDonald asked.

In adults, approximately 94 percent of the total body burden of lead is stored in the bones and teeth compared to approximately 73 percent in the bones and teeth of children, according to Zeitz Ruckart.

Bone lead has a half-life of years to decades. Although lead in blood represents only a portion of the total body burden, a blood lead test is the best readily available way to assess a persons exposure to lead, Zeitz Ruckart said.

There are many different factors that affect blood lead levels such as the source of exposure, length of exposure, and underlying susceptibility (childs age, nutritional status, and genetics)," Zeitz Ruckart added. "Even in the absence of exposure, blood lead levels can rise during periods of bone turnover, which include periods of growth, metabolic disease, pregnancy, lactation, osteoporosis.

The issue of lead is a complex issue and often new studies are published that reveal more issues and findings as to how lead works and its harmful effects on humans, according to Hanna-Attisha.

McDonald said she talks to her daughter frequently about the lead situation because she knows its a lot for a child to understand.

She had dental surgery back in 2015, because of all the corrosion in her mouth, McDonald said. They put a lot of caps and stuff in her mouth and a bar.

Hanna-Attisha noted in regard to teeth about national studies that showed kids who drank bottled water had more cavities and worse teeth, but less lead exposure.

Healthy Kids Dental has been in the area for quite some time and it offers free dental care for those who are on Medicaid. The Flint Registry refers kids to Mott Dental as well, according to Hanna-Attisha.

Takisha Moller was pregnant with her daughter Destinee Wilson in 2014, the year the city switched its water supply.

I tasted metal when I was pregnant, like every time the water was boiled, I tasted metal and I told him (Destinees father), I cant drink this water, it tastes like metal. But I kept drinking it, Moeller said. I drank it all the way until they finally said lead was in the water, but that was after she was born.

After Mollers daughter was born she continued to boil the water, just as the city advised, to give her newborn baths.

I was feeding my baby lead all this time, drinking all this water, giving her baths in the lead water and I know it can soak through your skin and all of that so my first thought was: Is her brain going to be OK? Because she lived in my womb for 10 months - I was overdue. I was just worried about her well being and her development and stuff.

When Destinee was three or four months old, Moller remembers the city dropping bottled water off at her home for the family to drink, cook and clean with.

Sometimes I want to ignore it, Moller said of the issues shes noticed in her daughter. Sometimes I want to look past it, but you have to face it.

At nearly 2 years old, Moller observed her daughter wasnt making any strides toward talking. The toddler can be aggressive and she has a learning disability, the mother added.

Its just going to be a watch and wait game, I guess, Moller said as she sighed.

While Moller was growing her baby, fibroid tumors were also growing inside her uterus. The mother of one is scheduled to have a hysterectomy.

So now, I cant have any more kids because Im having a hysterectomy soon. I was just pregnant in February, Moller said. They gave me a surgery a year after Destinee was born to remove some of the fibroid tumors, they took them out but they grew back.

Moller said doctors told her the tumors are related to her drinking the lead water.

I try not to think about it, Moller said before she took a long pause. Im a very positive person. I have been through a lot in my life, so I have learned to take the bad things and spin them into something positive for myself because I understand that no matter what happens, the past is the past and you create your own future.

Lead prevention

Childhood lead poisoning is entirely preventable, according to both Hanna-Attisha and Zeitz Ruckart.

Theres no magical treatment besides prevention, Hanna-Attisha said. So when we realized theres not a magic pill we can give our patients, our focus became: what can we do to limit the impact of this exposure?

The focus of the Neurodevelopmental Center of Excellence studies how learning and behavior are related to brain development and neural networks through comprehensive neuropsychological assessments.

The center is a resource to help with secondary prevention of lead, said Hanna-Atttisha.

Things that help can help with secondary prevention include good nutrition, educational enrichments and mental health support.

Children can be buffered from a lot of those issues if its implemented in their lives, Hanna-Attisha said.

The Flint Registry, a tool built by the community of Flint to connect people to services and programs to promote health and wellness while navigating a health crisis, can provide support for families in those areas.

A partnering program to help provide good nutrition to the families of Flint is the nutrition prescription program, managed by Michigan State University and Hurley Childrens Hospital Pediatric Public Health Initiative, where $15 for healthy foods are prescribed to young patients by their pediatrician.

Chantel Dawson, research assistant for the nutrition prescription program, collects data from the program.

We aim to help individuals maintain a healthy lifestyle - dietary changes, like longevity, Dawson said. So with the program, we provide a prescription for $15, which can be redeemed at the Farmers' Market or it can also be redeemed at our mobile market, which is Flint Fresh.

Dawson said shes noticed more families have been taking advantage of the prescription since the pandemic.

Ive had individuals tell me that they saved it (the prescription) for Thanksgiving and they cooked a healthy Thanksgiving meal with nothing but vegetables, Dawson said. We had individuals even during the pandemic who werent receiving unemployment or any type of food assistance and they were relying on their appointment with their doctor because if they cant go to the clinic, we also offer services via telehealth.

Dawson said one of the things the program has focused on in the last several months is accessibility. The program has now expanded its delivery services outside of Flint and throughout Genesee County.

We are trying to make sure that we give them accessibility still during the hardest times that were going through, Dawson said.

The CDC supports state and local health departments through cooperative agreements to support childhood lead poisoning prevention activities including strengthening: blood lead testing and reporting, surveillance, linking children to recommended follow-up services, and targeted population-based interventions, according to Zeitz Ruckart.

Our work in recovery is holistic, said Hanna-Attisha. Nobody says that this water crisis was just a lead crisis because it it so much more than that. We have been framing everything as a trauma, this was one trauma and really leaning on the science of trauma and being trauma informed and thats kind of driven our holistic science-based community driven response.

Related news:

Leaders urge citizens impacted by Flint water crisis to get help through the Flint Registry

Flint families ponder what the water crisis settlement really means for them

12 critical moments in the history of the Flint water crisis

Original post:
Flint children exposed to lead suffer from dental problems, learning disabilities, other issues - MLive.com

Read More...

The Importance of Deep Water in Fall Bass Fishing – Wired2Fish

Sunday, October 25th, 2020

As the calendar gets closer to November and December, it's imperative to keep a close eye out for a fall spawn. The large majority of anglers would tell you that bass only spawn in the spring, but that's simply not true. According to nationally renowned fisheries biologist Steven Bardin, it's much more common than you'd think, especially with Florida-genetic bass. And guess what? Florida-genetic bass are becoming increasingly prevalent throughout the country.

"We all know that the spawn starts in the spring," Bardin said. "Those bass will come to bed when the water temperatures reach around 65 degrees. The largest females spawn first, but they don't drop all of their eggs initially. They only drop 50 percent of their eggs at first. They they'll leave that bed and find another bed about a month later. Then they'll do it a third time.

"When summer rolls around, they start producing eggs for the next year. If we have a fall with a prolonged warm stretch, those eggs will ripen and they'll go ahead and spawn. You'll see this more often in low bass-density fisheries when competition is low. So when a one- or two-week warm snap occurs and combines with low density, you'll see a lot of fall spawning."

For the longevity of the hatched fry, this fall spawn has its pros and cons.

"When a bass spawns early, such as in the late fall, their fry will be bigger when all of the other bass spawn in the spring," Bardin said. "That fry will be nearly 3 inches and now it can outcompete the spring fry and even eat them. On the other hand, however, a big female with great genetics can spawn in the fall and then a cold front comes and kills all of the fry. It's a risky proposition."

Bardin also notes that if the water is below 70 degrees during the fall and it suddenly spikes above the 70-degree mark for a week or two, a fall spawn will often be triggered. This doesn't mean you need to go look in dirt-shallow water like you would in the spring, though. Fall spawning activity tends to occur in-you guessed it-shallow areas with adjacent deep water.

This explanation makes a lot of sense to me. I caught the biggest bass of my life, a 13.14-pounder, on November 2, 2017 in two feet of water. I had no idea about the fall spawn at that point, to be honest. The water was a little dirty and I was mindlessly flipping a creature bait at the same limb for about 10 minutes while I was having a conversation with a buddy. After countless flips, I felt a little "tick" at the end of my line and it was game-on.

Bardin isn't just a biologist source for Wired2fish; he's also a friend of mine. So I called him after I caught and released the 13-pounder and he asked me what the weather had been like. I told him it was too warm that week to deer hunt, so I went fishing instead. He simply replied with, "Yep, she was on bed. You caught a fall spawner."

I went back and looked at the video of the catch and all of the pictures and sure enough, her tail was bloody and she looked like she was slap-full of eggs. She was also just a few yards from 15 feet of water. Although I didn't mean to catch her, it was a real eye opener to me. That fish catch changed my approach to fall fishing.

See the rest here:
The Importance of Deep Water in Fall Bass Fishing - Wired2Fish

Read More...

Genomic Biomarker Market Growth, Demands, CAGR, Sales Volume, Opportunities, Types, Applications and Forecast up to 2023 – The Think Curiouser

Sunday, October 25th, 2020

Market Overview of Genomic Biomarker Market

The Genomic Biomarker market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Genomic Biomarker market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.researchmoz.com/enquiry.php?type=S&repid=2812407&source=atm

Market segmentation

Genomic Biomarker market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

segment by Type, the product can be split intoOncologyCardiologyNeurologyNephrology

Market segment by Application, split intoHospitalsDiagnostic and research laboratories

Based on regional and country-level analysis, the Genomic Biomarker market has been segmented as follows:North AmericaUnited StatesCanadaEuropeGermanyFranceU.K.ItalyRussiaNordicRest of EuropeAsia-PacificChinaJapanSouth KoreaSoutheast AsiaIndiaAustraliaRest of Asia-PacificLatin AmericaMexicoBrazilMiddle East & AfricaTurkeySaudi ArabiaUAERest of Middle East & Africa

Regional analysis is another highly comprehensive part of the research and analysis study of the global Genomic Biomarker market presented in the report. This section sheds light on the sales growth of different regional and country-level Genomic Biomarker markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Genomic Biomarker market.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2812407&source=atm

The report offers in-depth assessment of the growth and other aspects of the Genomic Biomarker market in important countries (regions), including:

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, etc.)

Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Genomic Biomarker competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Genomic Biomarker sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Genomic Biomarker sales, revenue and market share for each player covered in this report.

In the competitive analysis section of the report, leading as well as prominent players of the global Genomic Biomarker market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.The key players covered in this studyBio-RadBeckman CoulterMyriad GeneticsThermo Fisher ScientificRocheQIAGENEpigenomicsAlmacPfizerHuman LongevityValiRxPersonalisEagle GenomicsEmpire GenomicsAgilentIllumina

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2812407&licType=S&source=atm

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Genomic Biomarker product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Genomic Biomarker, with price, sales, revenue and global market share of Genomic Biomarker in 2018 and 2019.

Chapter 3, the Genomic Biomarker competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Genomic Biomarker breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.

Chapter 12, Genomic Biomarker market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.

Chapter 13, 14 and 15, to describe Genomic Biomarker sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Contact Us:

ResearchMoz

Tel: +1-518-621-2074

USA-Canada Toll Free: 866-997-4948

Email: [emailprotected]

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfil all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organisations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Continued here:
Genomic Biomarker Market Growth, Demands, CAGR, Sales Volume, Opportunities, Types, Applications and Forecast up to 2023 - The Think Curiouser

Read More...

Does Family History Of Diabetes Mean That I Will Inherit It Too? – NDTV Doctor

Sunday, October 25th, 2020

A person is at risk of getting diabetes if s/he has family history of it. But the chances of getting diabetes depend on the person's lifestyle and several other risk factors. Read here to know.

Diabetes risks depends on factos like diet, lifestyle and level of physical activity

Diabetes is largely considered to be inherited, if our parents or anyone in our direct family has diabetes, there is a great possibility that you may inherit it.If you keep eating what your parents and grandparents ate, there is a good chance you will inherit their diabetes. The lifestyle you have so unknowingly inherited from your parents is making you ask this question! Let us get a few facts clear first. Research says that genetics account for 20% of lifestyle disorders, the rest is down to your lifestyle and the environment, of which lifestyle dominates at around 70%.

Having said that when we speak of type 2 diabetes, it is a lifestyle disorder (Type 1 diabetes is the result of a genetic defect and really has no natural cure for it). We call it a lifestyle disorder because it occurs as a result of what you eat, what you think, how you sleep, if you are active, what you do, basically a culmination of your day to day activities. This means, if you alter your lifestyle, there is a 70% chance that you will not inherit diabetes. Seems like a fair deal doesn't it? But you should know where you go wrong, and before diving deeper, be rest assured that your diet alone can have an alarming effect on type 2 diabetes.

Also read:Five Effective Ways To Manage Diabetes When Suffering From Kidney Disease

We fall prey to the whole genetics and mass psychology trap. We have been made to believe that we will inherit diabetes and other related disorders like cardiovascular disease and cancer just because our elders had them. Well, you do have a similar genetic structure, but you can definitely improve your knowledge on the subject of nutrition and how food forms the very essence of longevity. To take an example here, the whole claim of consuming more animal-based proteins to reduce weight and manage diabetes better is false. The science and research do not back this up 1. While it may give you short terms results, in the long term it proves to be highly detrimental.

We would often see that parents who do not exercise much have the same effect on their kids (ofcourse there will be exceptions from one generation to the other), and similarly if they enjoy junk food, so does the offspring. It is these habits that are being referred to. Also, it is important to note that there is a group of parents who are very health conscious, but is their knowledge on the subject sufficient to ensure that they kids do not inherit diabetes? Sadly, that is not the case. Today, what the food industry deems as healthy, actually isn't. How are we able to consume more and more packaged foods today? Why is the size of the fruit and vegetable corner at the supermarket reducing in size? Well, they don't want us to stay healthy 2. They have been fooling us for decades and we have ended up implementing it all without verifying the facts. This is called mass psychology and modern-day marketing folks. We humans tend to get swayed easily. An advertisement with an elite athlete showcasing a new protein rich snack is released and it has us all running to buy it.

Also read:Can Weight Loss Help You Control Blood Sugar Levels? Here's The Link Between Weight Loss And Diabetes

Open your minds and think for yourself for once. Do your research and listen to your body. Our bodies are designed to heal and repair themselves. Diabetes is just an abnormality that can be a thing of the past. There is enough evidence published that people who consume a predominantly vegetarian diet 3 and very little to none of animal-based produce, have shown greater improvement and resilience to health issues like diabetes, hypertension, obesity and heart disorders 4. A diet rich in vegetables, fruits, grains, cereals, nuts & seeds has been proven to promote healthier body weight and BMI, greater insulin sensitivity and hormonal balance.

Before concluding, there has to be a mention that the right kind of natural, plant-based vitamins and supplements should be consumed for preventing/reversing diabetes, and on the whole to maintain longevity and stay clear of any other lifestyle disorders 5. We often fail to realize the power our food possesses. When consumed in the concentrated form, it can have miraculous results in the body 6.

And the answer is NO, you will not inherit diabetes provided you do not blindly follow a lifestyle that has been inherited or falsely created by the food industry. Eat scientifically correct food, get enough sleep, keep moving and stay happy!

Following a healthy lifestyle can help in reducing the risk of diabetesPhoto Credit: iStock

Also read:Diabetes Risk Factors: These 5 Factors Can Increase Your Risk Of Diabetes

Sources:

1. C Xiao, A Giacca, A Carpentier, G F Lewis. Differential effects of monounsaturated, polyunsaturated and saturated fat ingestion on glucose-stimulated insulin secretion, sensitivity and clearance in overweight and obese, non-diabetic humans. Diabetologia. 2006 Jun;49(6):1371-9.

2. Zimmerman FJ. Using marketing muscle to sell fat: the rise of obesity in the modern economy. Annu Rev Public Health. 2011; 32:285-306.

3. R. Vegetarian Diets in the Prevention and Management of Diabetes and Its Complications. Diabetes Spectr. 2017;30(2):82-88.

4. Wright N, Wilson L, Smith M, Duncan B, Mchugh P. The BROAD study: A randomised controlled trial using a whole food plant-based diet in the community for obesity, ischaemic heart disease or diabetes. Nutr Diabetes. 2017;7(3):e256.

5. Beaudart C, Buckinx F, Rabenda V, Gillain S, Cavalier E, Slomian J, Petermans J, Reginster JY, Bruyere O. The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials. J ClinEndocrinolMetab. 2014 Nov;99(11):4336-45.

6. W Stonehouse, C A Conlon, J Podd, S R Hill, A M Minihane, C Haskell, D Kennedy. DHA supplementation improved both memory and reaction time in healthy young adults: a randomized controlled trial. Am J ClinNutr. 2013 May;97(5):1134-43.

Promoted

(Vaibhav Garg, Clinical & Sports Nutritionist and Founder, Purecise)

Disclaimer: The opinions expressed within this article are the personal opinions of the author. NDTV is not responsible for the accuracy, completeness, suitability, or validity of any information on this article. All information is provided on an as-is basis. The information, facts or opinions appearing in the article do not reflect the views of NDTV and NDTV does not assume any responsibility or liability for the same.

Follow this link:
Does Family History Of Diabetes Mean That I Will Inherit It Too? - NDTV Doctor

Read More...

Genomic Biomarker Market 2020 | Know the Latest COVID19 Impact Analysis And Strategies of Key Players: Bio-Rad, Beckman Coulter, Myriad Genetics,…

Monday, September 28th, 2020

Latest research report, titled Global Genomic Biomarker Market Insights, Forecast to 2025. this report included a special section on the Impact of COVID-19. Also, Genomic Biomarker Market (By major Key Players, By Types, By Applications, and Leading Regions) Segments outlook, Business assessment, Competition scenario and Trends .The report also gives 360-degree overview of the competitive landscape of the industries. SWOT analysis has been used to understand the strength, weaknesses, opportunities, and threats in front of the businesses. Moreover, it offers highly accurate estimations on the CAGR, market share, and market size of key regions and countries. Players can use this study to explore untapped Genomic Biomarker markets to extend their reach and create sales opportunities.

Top Key players profiled in the report include:Bio-Rad, Beckman Coulter, Myriad Genetics, Thermo Fisher Scientific, Roche, QIAGEN, Epigenomics, Almac, Pfizer, Human Longevity, ValiRx, Personalis, Eagle Genomics, Empire Genomics, Agilent, Illumina and More

To Get PDF Sample Copy of the Report(with covid 19 Impact Analysis): https://www.globmarketreports.com/request-sample/4134

Genomic Biomarker market competitive landscape offers data information and details by companies. Its provides a complete analysis and precise statistics on revenue by the major players participants for the period 2020-2025. The report also illustrates minute details in the Genomic Biomarker market governing micro and macroeconomic factors that seem to have a dominant and long-term impact, directing the course of popular trends in the global Genomic Biomarker market.

Market Segment By Type:OncologyCardiologyNeurologyNephrology

Market Segment By Application:HospitalsDiagnostic and research laboratories

Regions Covered in the Global Genomic Biomarker Market: The Middle East and Africa (GCC Countries and Egypt) North America (the United States, Mexico, and Canada) South America (Brazil etc.) Europe (Turkey, Germany, Russia UK, Italy, France, etc.) Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Years Considered to Estimate the Market Size:History Year: 2015-2019Base Year: 2019Estimated Year: 2020Forecast Year: 2020-2025

Get Chance of up to 30% Extra Discount @ https://www.globmarketreports.com/request-discount/4134

Some Major TOC Points:

For More Information with including full TOC: https://www.globmarketreports.com/industry-reports/4134/Genomic-Biomarker-market

Customization of the Report:Glob Market Reports provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Get Customization of the [emailprotected]:https://www.globmarketreports.com/report/request-customization/4134/Genomic-Biomarker-market

Get in Touch with Us :Mr. Marcus KelCall: +1 915 229 3004 (U.S)+44 7452 242832 (U.K)Email: [emailprotected]

See the original post:
Genomic Biomarker Market 2020 | Know the Latest COVID19 Impact Analysis And Strategies of Key Players: Bio-Rad, Beckman Coulter, Myriad Genetics,...

Read More...

Precision Medicine Software Market by Trends, Dynamic Innovation in Technology and 2025 Forecasts | Covid-19 Analysis – The Daily Chronicle

Monday, September 28th, 2020

In this report, we analyze the Precision Medicine Software industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2014 to 2019. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2014 to 2019. We also make a prediction of its production and consumption in coming 2019-2024.

Request sample copy athttps://www.reportsintellect.com/sample-request/1055238?utm_source=apsters&utm_medium=24

At the same time, we classify different Precision Medicine Software based on their definitions. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What is more, the Precision Medicine Software industry development trends and marketing channels are analyzed.Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.

Key players in global Precision Medicine Software market include:SyapseAllscriptsQiagenRoper TechnologiesFabric GenomicsFoundation MedicineSophia GeneticsPierianDxHuman LongevityTranslational SoftwareGene42, IncLifeomic Health

Inquire for a Discount at https://www.reportsintellect.com/discount-request/1055238?utm_source=apsters&utm_medium=24

Market segmentation, by product types:Cloud-basedOn-premise

Market segmentation, by applications:Healthcare ProvidersPharmaceutical and Biotechnology CompaniesResearch Centers and Government InstitutesOthers

Market segmentation, by regions:North AmericaEuropeAsia PacificMiddle East & AfricaLatin America

The report can answer the following questions:1. What is the global (North America, South America, Europe, Africa, Middle East, Asia, China, Japan) production, production value, consumption, consumption value, import and export of Precision Medicine Software?2. Who are the global key manufacturers of Precision Medicine Software industry? How are their operating situation (capacity, production, price, cost, gross and revenue)?3. What are the types and applications of Precision Medicine Software? What is the market share of each type and application?4. What are the upstream raw materials and manufacturing equipment of Precision Medicine Software? What is the manufacturing process of Precision Medicine Software?5. Economic impact on Precision Medicine Software industry and development trend of Precision Medicine Software industry.6. What will the Precision Medicine Software market size and the growth rate be in 2024?7. What are the key factors driving the global Precision Medicine Software industry?8. What are the key market trends impacting the growth of the Precision Medicine Software market?9. What are the Precision Medicine Software market challenges to market growth?10. What are the Precision Medicine Software market opportunities and threats faced by the vendors in the global Precision Medicine Software market?

Objective of Studies:1. To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global Precision Medicine Software market.2. To provide insights about factors affecting the market growth. To analyze the Precision Medicine Software market based on various factors- price analysis, supply chain analysis, Porte five force analysis etc.3. To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia, Latin America and Rest of the World.4. To provide country level analysis of the market with respect to the current market size and future prospective.5. To provide country level analysis of the market for segment by application, product type and sub-segments.6. To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.7. To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Precision Medicine Software market.

About Us:-

Reports Intellect provides Research Reports for everything related to market research and market intelligence. We are aware of trade importance and market need in todays competitive world.

Our team works efficiently to fetch the most authentic research reports backed with perfect data figures that guarantee outstanding results every time for you and your business.

Whether it is the latest report from the researchers or a custom demand feel free to contact us. We are available 24 hours for our beloved clients.

Contact Us:

[emailprotected]

PH + 1-706-996-2486

Read more here:
Precision Medicine Software Market by Trends, Dynamic Innovation in Technology and 2025 Forecasts | Covid-19 Analysis - The Daily Chronicle

Read More...

Page 5«..4567..10..»


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick